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Abstract
The juvenile form of Batten Disease (JNCL) is an autosomal recessive 
neurodegenerative disease caused by mutations in the CLN3 protein, an integral 
membrane protein of unknown function. The hallmark of JNCL is the accumulation 
of storage material in lysosomes consisting predominantly of subunit c of 
mitochondrial ATP synthase.
CLN3 protein is present primarily in endosomes and lysosomes in non­
neuronal cells, whereas in neuronal cells it is also reported to be in presynaptic 
vesicles and along the neurites. The current best evidence is that it traffics through the 
endoplasmic reticulum and Golgi apparatus to the endosome and lysosome, sorted by 
a dileucine m otif which binds the adaptor complexes AP-1 and AP-3.
The effects of loss of CLN3 protein function on membrane trafficking were 
investigated in the knockout mouse model and in human cell lines deficient
for CLN3 due to siRNA-mediated gene silencing. Morphological analysis and 
immunostaining of CLN3-deficient fibroblasts and neurons revealed the presence of 
normal lysosomes but also an accumulation of aberrant organelles of autophagic 
origin.
Endocytic tracer analysis indicated that the aberrant organelles accumulate due 
to a defect in fusion between autophagosomes and lysosomes. Phagocytic defects 
involving a failure to recruit late endocytic markers were also defined. Together these 
findings indicate a similar defect in both these cellular pathways, involving defective 
maturation o f autophagosomes and phagosomes which is accompanied by 
accumulation of undigested material in CLN3-deficient cells.
As well as impairments in the mechanism of endosome fusion with 
autophagosomes and phagosomes, defects in an additional cellular mechanism were 
detected in CLN3-deficient cells. The route of protein trafficking from the trans-golgi 
network (TGN) to endosomes is interrupted after CLN3 gene silencing, resulting in 
retention of the cation-independent mannose- 6 -pho sphate receptor in the TGN 
accompanied by defective processing of lysosome hydrolases.
This investigation of the cellular pathology underlying Batten disease reveals a 
role for CLN3 in two distinct but related cellular pathways: autophagyc and 
phagocytosis and it also plays a role in TGN to endosome trafficking. This contributes 
to the understanding of the cellular phenotype underlying CLN3/Batten disease and 
most likely other forms of neuronal ceroid lipofuscinosis.
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Chapter 1 Introduction
1 Introduction
1.1 Neuronal ceroid lipofuscinoses (NCL) or Batten disease
The neuronal ceroid lipofuscinoses (NCLs) are a genetically heterogeneous group of 
recessively inherited disorders which collectively form the most common 
neurodegenerative diseases of childhood, with an incidence as high as 1:12,500 live 
births (Santavuori, 1988) (Rider and Rider, 1999){the neuronal ceroid lipofuscinoses, 
H.H. Goebel, Eds}. There are at least ten clinically defined related NCL subtypes, and 
with the recent confirmation that cathepsin D and MFSD8 deficiency causes a human 
NCL subtype, a total o f  eight NCL genes have been characterised (Cooper, 2003) 
(Siintola et aL, 2007; Siintola et a l ,  2005; Steinfeld et al., 2006).
Recently mutations in chloride channels CLC-6 and CLC-7 present in late endosomes 
and lysosomes have also been proposed as NCL-causing genes (Kasper et aL, 2005; 
Poet et aL, 2006).
NCL disorders are lysosomal storage disorders characterized by widespread 
intracellular accumulation of autofluorescent lipopigment in patient’s tissues. NCL 
brains show neuronal cell atrophy and neuronal loss including a neuronal loss in the 
retina {the neuronal ceroid lipofuscinoses, H.H. Goebel, Eds}.
NCLs have traditionally been diagnosed based on the age at onset and distinct 
ultrastructure of the storage material. Four forms of NCL were initially identified, 
classified as infantile (INCL); late-infantile (LINCL); juvenile (JNCL) and adult 
(ANCL). Various late-infantile subgroup variants have been defined (Table 1-1) 
(Kyttala et aL, 2006).
Patients suffer from uncontrollable seizures, visual failure, cognitive and motor 
decline and ultimately premature death. At present there is no effective therapy 
(Cooper, 2003) (Dyken, 1988).
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Table 1-1 NCL classification
Clinical subtype Gene Protein
Congenic Cat D Cathepsin D aspartic protease
Infantile
Late-infantile, 
1. Classic
CLN1 Palmitoyl protein thioesterase 1
CLN2 Tripeptidyl peptidase 1
2. Finnish variant CLN5 Soluble lysosome protein
3. Variant
4. Turkish
CLN6 ER membrane protein
CLN7 MFSD8 putative transporter
Storage phenotype
GROD
Saposin A+D/subunit c
GROD 
Saposin A+D
CL
Subunit c
FP/CL 
Subunit c
FP/CL 
Subunit c
FP/CL
9
5. N. epilepsy/EMPR CLN8 ER-ERGIC membrane protein RL
Subunit c
Juvenile CLN3 Late endosome, lysosome 
membrane protein
FP
Subunit c
1.1.1 Pathology of NCLs
The characteristic feature of NCL pathology is the intra-lysosomal accumulation of 
autofluorescent proteolipid in the brain and other tissues (Koenig, 1964) (Haltia et a l, 
1973) (Goebel, 1995). By electron microscopy, the electron dense accumulations have 
different appearances, depending on the NCL subtype. The ultrastructural morphology 
o f the storage inclusions is used diagnostically and these subtypes have been classed 
as granular osmiophilic deposits (GRODs), curvilinear profiles (CL), rectilinear
12
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profiles (RL) and fingerprint bodies (FP). Some NCL forms have a mixture of FP and 
CL/RL (Goebel et aL, 1999).
The storage material present in the lysosomes is composed o f a lipid-protein 
complex. The protein content varies and consists predominantly of either subunit c of 
the mitochondrial ATP synthase complex (FO/Fl-ATP-ase) in subtypes CLN2, 3, 4, 5, 
6, 7, 8, or predominant of saposins A and D in CLNl (Palmer et aL, 1992).
Mitochondrial ATP synthase subunit c is normally found as a component of the 
mitochondrial ATP synthase complex located on the inner mitochondrial membrane. It 
is encoded by two genes PI and P2 (Ezaki et aL, 1995). In both sheep models and 
patients with NCL, unmodified subunit c accumulates in cells but these two genes 
have normal sequence and mRNA expression levels (Medd et aL, 1993). In addition 
the rate o f oxidative phosphorylation in NCL cells is normal (Ezaki et aL, 1995; 
Palmer et aL, 1992) suggesting that the subunit c accumulation is not due to its 
malfunction.
1.1.2 Juvenile Batten disease
The juvenile-onset form of NCL (JNCL), also known as Juvenile Batten disease is 
the most frequent subtype. JNCL is caused by mutations in the CLN3 gene which 
encodes the CLN3 protein The morphology and ultrastructure of the storage is of 
fingerprint bodies (Figure 1.1).
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Figure 1.1 Fingerprint profile of the storage material characteristic of JNCL.
Electron micrograph of storage fingerprint profile present in a patient with mutation in 
the CLN3 protein. Image by Dr Juhani Rapola.
1.2 CLN3
The CLN3 gene located on chromosome 16pl2.1 was isolated by positional cloning in 
1995, and has been shown to be responsible for JNCL by the identification of disease- 
causing mutations (Batten disease consortium, 1995) . There are now a total of 41 
characterised CLN3 mutations fhttn://www.ucl.ac.uk/ncl/l. A founder effect is seen in 
JNCL and the most common mutation of the CLN3 gene occurs in over 90% of 
patients. This is a 1 kb deletion in the genomic DNA, which removes exons 7 and 8. 
This mutation results in a truncated protein due to the loss of amino acids 154-438, 
and the introduction of 28 novel amino acids at the C terminal (Batten disease 
consortium, 1995).
The Cln3 gene consists of 15 exons and encodes a protein of 438 amino acids 
which has no known homology to other proteins. The CLN3 protein is conserved 
across all eukaryotes including C.elegans and yeast (Taschner et al., 1997). The 
function of CLN3 is not known, as discussed further in section 1.3.3.
There have been several computer prediction based models published of the 
structure of CLN3, each proposing that the protein is an integral membrane protein 
(Phillips et al., 2005). The topology has been predicted to comprise between five to
14
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eight transmembrane spanning regions (Janes et al., 1996) (Mitchison et al., 1997) 
(Ezaki et al., 2003) (Mao et al., 2003a) and more recent studies support six 
transmembrane domains with the both the C termini and N termini positioned towards 
the cytosol (Kyttala et al., 2004) (Storch et al., 2004) (Figure 1.2).
310
lumen
212'161 1304 370
120' 138 235 280 394
cytosol
CaaX253 4242.4
438
Figure 1.2. CLN3 structure
The topology of the 438 amino acid CLN3 protein is shown with the 6 transmembrane 
spanning regions and two lysosomal targeting motifs (in circles) reported in Kyytala 
et.ah, 2004. Both N and C termini are exposed towards the cytosol. The two N- 
glycosylation sites and C-terminal farnesylation site (CaaX) reported by Storch et. ah, 
2007 are also shown.
Originally several motifs were identified in CLN3 that could give clues to structure 
and function. These were: four putative N-glycosylation sites, 2 O-glycosylation sites, 
2 glycosaminglican attachment sites, 2 cAMP and cGMP dependent protein kinase 
phosphorylation sites, 6 protein kinase C phosphorylation sites, 8 casein kinase 11 
phosphorylation site, 12 N-myristoylation sites and a farnesylation site at the C- 
terminal (Batten disease consortium, 1995). CLN3 appears to be reatively heavily 
glycosylated. Glycosylation of lysosomal enzymes targets them to the lysosome and 
may protect them from being degraded. A glycosylation motif was indentified at the N 
terminus. N-linked glycosylation sites can be important for the right localization of a
15
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protein (Jarvela et aL, 1998). CLN3 has two lysosomal targeting motifs (Ezaki et aL,
2003) (Kyttala et aL, 2004) (Storch et aL, 2004).
1.2.1 CLN3 localization and trafficking
Several groups have studied the localization of the CLN3 protein with varying results. 
The current best evidence is that CLN3 protein traffics through the ER and Golgi to 
the endosome and lysosome with a proportion cycling via the PM (Jarvela et aL, 1998) 
(Haskell et aL, 1999) (Mao et aL, 2003a).
Most of the work done on understanding CLN3 localization has been carried out on 
cells overexpressing the protein, since CLN3 expression level is too low to detect the 
endogenous protein. Initial reports of CLN3 localization in the Golgi are thought most 
likely to be artefacts o f protein-tagging experiments (Kremmidiotis et aL, 1999) 
(Jarvela et aL, 1999) (Haskell et aL, 2000). CLN3 has been localised to the ER (Jarvela 
et aL, 1998), endosome/lysosome (Golabek et aL, 1999; Kyttala et aL, 2004; Storch et 
aL, 2007) and plasma membrane (Jarvela et aL, 1999) (Mao et aL, 2003a) in somatic 
cells.
In neuronal cells CLN3 has been proposed to be in synaptic vesicles (Haskell et aL,
1999), the nucleus and the cytoplasm (Margraf et aL, 1999). Other work carried out 
analyzing retinal neurons provides evidence that CLN3 is targeted to the neuronal 
synapse (synaptosomes) but excluded from synaptic vesicles (Luiro et aL, 2001).
Detection of murine endogenous CLN3 has been reported in immortalized 
cerebellar neuronal precursor cells lines (Fossale et aL, 2004) and in mouse retinal 
cells (Luiro et aL, 2001). The endogenous protein was shown to co-localise with the 
lysosomal marker LAMPl but more markedly with the early endosomal antigen EEAl 
and the late endosomal marker Rab7 (Fossale et aL, 2004). Limited overlap was 
observed with transferrin receptor, which is a marker o f recycling early endosomes. 
Lysosomal targeting of CLN3 appears to be facilitated by two targeting motifs, an 
unconventional motif in the C-terminal cytosolic tail consisting o f a methionine and a 
glycine separated by nine amino acids [M(X)9G], and a more conventional dileucine- 
type motif in a cytoplasmic loop domain preceded by an acidic patch (Mao et al.,2003)
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(Kyttala et al., 2004) (Storch et al., 2004). Deletion of both lysosomal targeting motifs 
abolishes targeting of the CLN3 protein to the lysosomes (Kyttala et aL, 2005). 
Recently, a C terminal prénylation motif was also proposed as a facilitator of 
lysosomal targeting (Storch et aL, 2007).
A small proportion of CLN3 has been reported to be present at the plasma 
membrane, and this suggests that at least some CLN3 may recycle through the plasma 
membrane en route to the endocytic system (Jarvela et aL, 1998). On the other hand 
studies on embryonic testicular carcinoma cells in which expression of the p3A 
subunit of the adaptor protein AP-3 had been silenced, showed upregulation of CLN3 
at the plasma membrane demonstrating that at least a proportion of CLN3 likely goes 
to the lysosomes directly under normal circumstances in a AP-3 dependent manner 
(Mao et aL, 2003b).
Evidence has been presented that the CLN3 dileucine motif binds both the adaptors 
AP-1 and AP-3 in vitro, and that the dileucine targeting motif alone is not able to sort 
CLN3 when one o f the two adaptors is impaired (Kyttala et aL, 2005). In fact CLN3, 
when its sorting depends on the dileucine motif, accumulates within the Golgi in AP-3 
deficient fibroblasts. In AP-1 deficient fibroblasts it is mistargeted into transferrin 
positive structures and the plasma membrane. Therefore it is most likely that CLN3 
traffics from the Golgi to the endosomes via AP-1 or AP-3 and is subsequently sorted 
from the endosomes to lysosomes via AP-1 or AP-3. Whichever adaptor proteins are 
specifically involved, CLN3 traffics to the endosomes before going to the final 
destination, which is the lysosome.
However it should be noted that another study disagreed with these finding, 
showing that CLN3 does not interact with AP-1, AP-3 or the GGAs (Storch et aL,
2004).
1.3 Mouse models for Juvenile Batten disease (JNCL)
17
Chapter 1 Introduction
To facilitate studies on Batten disease pathogenesis and treatment, Cln3-deficient 
mice were created by homologous recombination and targeted disruption of the 
murine Cln3 gene.
Four mouse models of juvenile onset NCL have been created so far by different gene 
targeting strategies. Cln3 knockout mice were made by insertion mutation using the 
neomycin selectable marker cassette to disrupt the Cln3 gene by replacement of exon 
1-6 (Mitchison et al., 1999) or of exon 7-8 (Katz et al., 1999). A more subtle mutation 
was created to make ClnS knock-in mice using cre-lox technology, such that Cln3 
exon 7 and 8 were deleted, replaced by a single loxP site that was left in intronic 
sequence between exon 6 and 9 (Cotman et al., 2002). This is a genetically accurate 
model, exactly mimicking the major CLN3 1 Kb deletion, which removes exon 7 and 
8 .
Recently a new reporter knock out mouse model was produced by insertion of a 
neomycin-8 galactosidase cassette to disrupt the gene by replacement of exon 1-8 and 
simultaneously report gene expression from the endogenous Cln3 promoter. This 
allows study of CLN3 expression during embryogenesis and development to correlate 
the expression of CLN3 with the behaviour of the animals (Eliason et al., 2007).
All the mice models are viable and fertile but die prematurely with a late stage 
neurological phenotype recapitulating cell biological and pathological features of 
Batten disease (Cotman et al., 2002; Katz et al., 1999; Mitchison et al., 1999) (Eliason 
et al., 2007). Two of the models are not yet characterized (Eliason et al., 2007; Katz et 
al., 1999).
1.3.1 Cln3 mice as a model to study CLN3
The mouse model used in this thesis was the exon 1 -6 deletion model mentioned in the 
previous paragraph (Mitchison et al., 1999) (hereafter referred to as "Cln3 KO'). Cln3 
KG mice reproduce many of the features which characterize patients with JNCL. The 
mice start accumulating storage material from the age of 3 weeks, but do not display 
obvious clinical symptoms until around 16 months of age (Mitchison et al., 1999). 
Mice die around 18-20 months (Pontikis et al., 2004).
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The storage material is autofluorescent and positive for the subunit c of the 
mitochondrial ATPase, similarly to JNCL patients.
Widespread degeneration and loss of neurons occurs in the central nervous system 
from 7 months, predominantly the cortex and cerebellum and this is accompanied by 
hypertrophy of many interneurons in the hippocampus.
Deterioration of vision due to retinitis pigmentosa is typically the first clinical sign 
to manifest in children with Juvenile Batten disease from the age of 4-8 years. One of 
the primary insults within the retina is the death of photoreceptors (Bensaoula et al.,
2000). In ClnS KG mice retinal function appears relatively well preserved (Seigel et 
aL, 2002) but there are deficits in optic nerve conduction accompanying degenerative 
loss of cells within the central visual processing regions of the brain, and this is 
proposed to precipitate the visual deterioration associated with CLN3 deficiency. A 
selective loss of the large retina-recipient projection neurons within the dorsal portion 
of the lateral geniculate was also observed (Weimer et al., 2006).
At the organelle level in addition to the presence of the storage of material, which 
accumulates in the cells, abnormal mitochondria were observed in brain tissue by 
electron microscopy investigation (Jolly et al., 2002).
Other reported findings from analysis of the mouse brains indicated decreased activity 
of glutamic acid decarboxylase resulting in elevated glutamate levels (Chattopadhyay 
et al., 2002). Also AMP A receptor function was found to be enhanced in cerebellar 
granular cells and suggested CLN3 could have a role directly or indirectly affecting 
the cycling of the receptor (Kovacs et al., 2006).
Currently, there is debate over the mechanism of neuronal cell death with evidence 
of both apoptosis and autophagy (Mitchison et al., 2004). In particular autophagy was 
reported in the mouse model around 12 months of age with findings that degenerating 
neurons from cortex were crowded with autophagic vacuoles and did not present any 
sign of apoptosis (Mitchison et al., 2004).
In the retina it appears clear that photoreceptors die by apoptosis (Seigel et al., 
2002).
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1.3.2 Ctn3 knock-in mouse
To investigate the common CLN3 1 Kb mutation, an identical genomic DNA 
deletion (the elimination of the exons 7 and 8) was introduced into the murine CLN3 
homologue, to create knock-in mice (Cotman, 2002 ).
Like Cln3 KO mice, mice exhibit typical JNCL cellular features including
accumulation of mitochondrial ATPse subunit c positive storage material in 
fmgerprint-like inclusions. However, the neurological deficits are more marked and 
the mice also have a worse survival span, indicating a more severe classical 
phenotype. It is suggested that some features such as retinal degeneration in this 
mouse may be connected with the different strain background in addition to the 
different mutation and different housing. The knock-in mice were on 129/Sv-CDl 
strain, while the Cln3 KO were on 129/Sv-C57BL isogenic or mixed strain, and the 
CDl strain is known to have visual deficits (Cotman, 2002). However, the possibility 
remains that the severity of the phenotype is connected to the specific mutation.
Homozygous mutant mice displayed storage accumulation in peripheral
cells and brains, evident from the E l9.5 embryonic stage in liver, cerebellum, in 
neurons of the dentate gyrus and in the sub ventricular zone of the lateral ventricle. 
Degeneration of retinal neurons, CNS reactive astrocytosis, neurological deficits and 
reduced survival were also observed. This suggests that the disease starts before birth 
and this process does not perturb normal CNS development, but instead causes the 
demise of mature neurons(Cotman et al., 2002) as also proposed for the CIn3 knock 
out mouse model.
RT-PCR amplification of Cln3 mRNA from peripheral tissue and brains
showed that the common mutation yields multiple stable mRNA splice variants. The 
longest mutant cDNA is predicted to encoding a truncated 38kDa protein comprising 
the N terminus (exons 1 -6) and C terminus (exons 9-15) of the Cln3 gene, with a novel 
29-residue midsection encoded by a frameshifted exon 6. If mutant Cln3 protein exists 
and is expressed from these splice variants, this could create a different effect on cell 
homeostasis to that arising from complete absence of the protein, which is the
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presumed situation in the Cln3 KO mouse though RT-PCR analysis of the Cln3 knock 
out model is not completed so there is no direct comparison yet. However, since 
adequate antibodies are not yet available to detect endogenous protein, there is no 
definitive proof of presence or absence of mutant protein in any of the Cln3 mutant 
mice.
1.3.3 CLN3 functions
The function of the CLN3 protein remains unclear. The hallmark of JNCL is the 
accumulation of subunit c of the mitochondrial ATPase. For this reason several groups 
investigated the degradation capacity of CLN3 deficient cells with particular focus on 
the processing of the enzymatic activity of cathepsin D, which is required for subunit c 
degradation (Kominami et al., 1995) . Defects in cathepsin D processing were found 
but give conflicting results. In HEK cells overexpression of the CLN3 protein tagged 
to GPP revealed a higher level of the precursor and intermediate forms of cathepsin D 
whilst CLN3 knock down induced with anti sense transfection resulted in an increased 
amount of the mature form (Golabek et al., 2000).
In contrast, immortalized cerebellar cells from the Cln3^^^’^^  mouse showed a reduced 
precursor and mature forms but an elevated intermediate form of cathepsin D (Cao et 
al., 2006). The difference between the two cells lines could be due to use of anti sense 
RNA in the first case and the use of Ikb deletion cells in the second giving different 
cellular effects. Indirect immunofluorescence of cathepsin D in cerebellar
cells showed more perinuclear and less cytoplasmic punctate signal than in the wild 
type suggesting defective targeting to lysosomes. Analysis of the growth media did not 
shown altered levels of cathepsin D, excluding an increase in secretion and their 
cathepsin D total enzymatic activity was not different from the wild type (Fossale et 
al., 2004).
These results suggest that altered distribution and levels of mature cathepsin D enzyme 
do not appear to give rise to an enzyme defect that could be responsible for subunit c 
accumulation. More recent knockdown studies did not indicate a great cathepsin D
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processing alteration but a slight decrease in mature enzyme was noted in fibroblasts 
derived from CLN3 Ikb deletion patients (Pohl et al., 2007).
1.3.3.1 The CLN3 protein influences Lysosomal pH
The role of CLN3 in pH regulation has been debated with varying results 
depending on the cell and mutation type investigated. The yeast protein B tnlp is 39% 
identical and 59% similar to CLN3(Pearce and Sherman, 1997). B tnlp localizes to the 
vacuole, which is the equivalent to the lysosome (Croopnick et al., 1998; Cachet et al., 
2005).. In the fission yeast S.Pombe, Btnlp traffics to the vacuole membrane via early 
endocytic and pre-vacuolar compartments in a Rab7-dependent manner (Cachet et al.,
2005). An S. cerevisiae yeast strain lacking the Btnl protein was shown to have a 
lower than normal vacuolar pH during early growth that becomes normalized by later 
growth stages (Pearce et al., 1999). Studies on human CLN3 have also revealed that 
mutation of CLN3 results in a disruption of lysosomal pH. HEK293 cells transfected 
with antisense-oriented CLN3 cDNA demonstrated significantly lower pH than non 
treated controls (Colabek et al., 2000). However in JNCL patient cells the 
intracellular/lysosomal pH has been shown to be elevated rather than reduced 
(Holopainen et ah, 2001), and in Btnl deficient S.Pombe mutant fission yeast strain 
the vacuoles are also more alkaline. In the S.Pombe Btnl yeast model, Btnl-deficiency 
results in enlarged vacuole size, and overexpression of Btnlp reduced both vacuole 
diameter and pH in a complementary manner (Cachet et al., 2005).
1.3.3.2 Role of CLN3 in arginine transport
The S. cerevisiae yeast strain lacking Btnlp was shown to have a defect in inward 
vacuolar transport of arginine and this defect was shown to be complemented by 
expression of human CLN3, suggesting that altered vacuolar/lysosomal pH might be a 
consequence of altered transport of small molecules into the vacuole(Kim et al., 2003). 
However, the physiological significance of arginine transport into the vacuole (rather 
than out) is not known. B tnlp and CLN3 do not share sequence homology to any
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known transporter, therefore CLN3/Btnlp may not actually transport arginine but 
rather may play a role in the regulation of transport at the lysosomal/vacuolar 
membrane. Lysosomal arginine transport is ATP, vATPase and cation-dependent. In 
cells from JNCL patients there is also evidence of a defect in arginine transport into 
the lysosomes, resulting in depleted internal lysosomal arginine levels (Ramirez- 
Montealegre and Pearce, 2005). This defect seems CLN3-speeific, since it is not seen 
in INCL or Niemann-Piek patients.
1.3.3.3 Other proposed functions for CLN3
It has been proposed that CLN3 function could be connected to maintenance of the 
integrity of the cy to skeleton. The overexpression of CLN3 induces aggregation of the 
microtubule binding protein HOOKl (Luiro et al., 2004), which was shown to be 
upregulated in Btnl-deficient S.cerevisiae (Pearce et al., 1999). It was suggested that 
perhaps CLN3 mediates HOOKl dissociation from the mierotubules, providing a link 
between CLN3 and the cytoskeleton. CLN3 was shown to weakly interact with 
HOOKl which in turn interacts with Rab7, Rab9 and Rabl 1 (Luiro et al., 2004).
CLN3 was also found to interact in an vitro binding assay with CLN5, a soluble 
mannose-6-phosphate modified lysosomal protein of unknown function (Isosomppi et 
al., 2002). Mutations in CLN5 cause late-infantile Batten disease (Vesa et al., 2002). 
CLN3 has recently been proposed to have a novel palmitoyl protein A-9 desaturase 
function, implying it could function as a degradative enzyme that converts membrane 
associated palmitoylated proteins to their respective palmitoylated derivatives. 
Palmitoyl protein A-9 desaturase activity is deficient in the ClnS mouse KO (Narayan 
et al., 2006) and intermediate levels were detected in heterozygotes (Narayan et al., 
2007).
The CLN3 C-terminus is reported to interact with calsenilin. Calsenilin is increased in 
the Cln3 KO mouse signifying that CLN3 negatively regulates its cellular levels. 
Calsenilin is a multifunctional Ca^^ binding protein that interacts with presenilins and 
mediates calcium mediated apoptosis. An increase of calcium concentration causes
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significant dissociation of calsenilin from CLN3. CLN3 could therefore suppress 
calsenilin-induced cell death (Chang et a l, 2007).
t.4  Autophagy
1.4.1 The importance of autophagy in Batten disease
In the ClnS KO mouse model a loss of neurons occurs in the brains (Mitchison et a l, 
1999; Pontikis et al., 2004; Weimer et al., 2006). To investigate the process of death 
undergone by the neuronal cells, a detailed morphological investigation of the brain 
from the Cln3 KG mouse was made few years ago in a collaboration between Hannah 
Mitchison and Mark Turmaine (Anatomy, UCL).
Surprisingly, no sign of apoptosis was revealed after analysing the most severely 
affected regions of neuronal loss in the brains. Cells in the thalamus, hippocampus and 
cerebellum did not appear to contain any of the typical morphological signs including 
apoptotic bodies, cytoplasmic and chromatin condensation and DNA fragmentation 
characteristic of apoptosis. Interestingly, detailed EM analysis of degenerating and 
dying neurons revealed the presence of autophagosomes in the cytoplasm. Microglia 
cells which are the professional phagocytes of the brain also appeared swollen and full 
o f inclusions containing membraneous plus fingerprint profiles suggesting a successful 
engulfment of material but incapacity to degrade it. Astrocytes, in contrast, did not 
contain such huge storage accumulations.
The CLN3 autophagy phenomenon was confirmed during the course of the work 
presented in this thesis in immortalized cerebellar cell derived from the mice
where LC3-II, an autophagosomal marker, was increased in the deficient cells (Cao et 
al., 2006). Cerebellar cells transfected with GFP tagged LC3 and fed with lysotracker 
to stain the endocytic pathway showed less colocalization of the two markers in CLN3 
deficient cells than in wild type controls suggesting less encounters of the 
autophagosomes with the endocytic pathway (Cao et al., 2006).
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Since autophagy, a pathway that regulates mitochondrial turnover, was perturbated by 
deficiency of CLN3, this led to the conclusion that defects in autophagy could be the 
cause of the abnormal accumulation of the mitochondrial ATPase subunit c when 
CLN3 is deficient.
1.4.2 The autophagic pathway
Cytoplasmic components are degraded within the lysosome by microautophagy, 
chaperone-mediated autophagy and macroautophagy. In microautophagy, complete 
cytosolic regions are sequestered directly by the lysosome. This involves formation of 
invaginations of lysosomes to engulf components direcly, without any intermediate 
vesicles (Shintani and Klionsky, 2004). Chaperone mediated autophagy is applied only 
to cytosolic proteins with a specific lysosomal targeting motif. These are selectively 
recognised by a chaperone in the cytosol which delivers the proteins to the lysosome 
(Martinez-Vicente and Cuervo, 2007). A specific receptor recognizes the substrate and 
helped by a chaperone inside the lysosome, the substrate will get degraded. (Dunn, 
1990b)
In mammalian cells macroautophagy (from now on referred to as autophagy) is an 
important survival mechanism during short term starvation (Eskelinen et al., 2002).
The process of autophagy consists of four different steps: induction; formation of the 
autophagosome; docking and fusion of the newborn organelle with the lysosome; 
autophagic material break down (Klionsky and Emr, 2000).
After an induction signal, autophagy starts when a flat membrane cistema called a 
phagophore or isolation membrane wraps around a portion of cytoplasm, engulfing 
cytosol and the organelles in it. The origin of the phagophore remains to be discovered 
(Klionsky, 2005). The phagophore closes itself into a double membrane-bound 
vacuole, forming an initial autophagosomal organelle (Klionsky and Emr, 2000) 
(Mizushima et al., 2002). The autophagosome undergoes a process of maturation 
which includes contacts with the endocytic pathway consisting of fusion events with 
early endosomes and multivesicular bodies (AVI) (Liou et al., 1997) (Berg et al., 
1998). At the end of this maturation process, the mature autophagosome (AVI) fuses
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completely or kiss and run with a lysosome (Jahreiss et ah, 2008) allowing the 
lysosomal hydrolases to start the process of degradation of the internal 
autophagosomal material for eventual recycling of nutrients back to the cells. 
Autophagy can be selective or non selective. During selective autophagy, only some 
cargos are sequestered into autophagosomes and they contain little bulk cytosol. 
Selective autophagy has been reported so far in cases where bacteria and peroxisomes 
are being degraded. In non selective autophagy, autophagosomes primarily contain 
bulk cytoplasmic material (Xie and Klionsky, 2007).
Autophagic vacuoles can be characterized on the basis of the maturation process 
into early autophagic vacuoles containing morphologically intact cytoplasm and 
organelles, and late autophagic vacuoles containing partially degraded cytoplasm 
(Dunn, 1990a; Dunn, 1990b; Dunn, 1994).
The sequestration process started by the autophagosomes is orchestrated by a series 
o f autophagy related genes (Atg), first identified in yeast, and it is regulated by the 
mTOR kinase pathway. The activity of mTOR is controlled by insulin and other 
growth factors through the phosphatidylinostiol 3-kinase (PI-3) pathway. In normal 
conditions mTOR allows translation, ribosome biosynthesis and inhibits autophagy but 
in starvation conditions mTOR is inhibited, permitting autophagy. In this way mTOR 
acts as a master regulator of the balance between protein synthesis and degradation 
(Raught et al., 2001).
A protein called Beclin which is localized at the TON is important for 
autophagosome formation, where its association with P1-3K can produce PI3P (Kihara 
et al., 2001).
1.4.3 ATG genes
The ATG genes governing the autophagy pathway were discovered using yeast 
mutants defective in autophagy and have been discovered from studies of the 
biosynthetic cytoplasm to vacuole targeting (Cvt) pathway (Klionsky et al., 2003). Atg 
genes are listed in Table 1-2.
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Cloning of Atg genes revealed that they are all novel, except for Atg6 which was 
found to be identical to Vps30, a protein required for the sorting of carboxypeptidase 
Y (CPY) to the vacuole (Kametaka et ah, 1998). Atg6/Vps30 has distinct functions in 
the autophagic and vacuolar protein sorting pathway.
The byosynthetic Cvt and degradative autophagy pathways are similar and share 
most of the Atg components (Harding et ah, 1996). The Cvt pathway sequesters within 
double membrane bound vesicles (Cvt vesicle) at least two specific cargos, 
aminopepidase and mannosidase, which are synthesized in the cytosol, for their 
transport into the vacuole. In these vesicles the cytosol is excluded (Yorimitsu and 
Klionsky, 2005) (Figure 1.3). The Cvt pathway is not known outside yeast.
27
Chapter 1 Introduction
Table 1-2 Atg genes
Y east name Human homologue Role in autophagy
ATGl
ATG2
ATG4
ATG5
ATG6
ATG7
ATG8 
ATG9 
ATG 10
ATG 12 
ATG 13 
ATG 14
ATG 16
hATG5
Beclin
HsGSA/haPG
MAP1LC3
ATG9
hAPG12
Induction
Autophagosome formation 
(association with ATG9) 
Autophagosome formation 
(Atg8 conjugation system) 
Autophagosome formation 
(Atg 12 conjugation system) 
Autophagosome formation 
(forms a complex with Atg 14) 
Autophagosome formation 
(Atg 12 and Atg8 conjugation system) 
Autophagosome maturation 
Autophagosome formation 
Autophagosome formation 
(association with Atg 12) 
Autophagosome formation 
Induction
Autophagsome formation 
(complex with Atg6)
Autophagosome formation 
(association with Atgl2-Atg5 complex)
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Figure 1.3 Biosynthetic cytoplasm to vacuole targets (Cvt pathway) in yeast
Modified from (Klionsky, 2005 ).
During nutrient-rich conditions the protein kinase TOR inhibits the autophagic 
pathway but starvation inhibits TOR, allowing the formation of autophagic vacuoles. 
In yeast, there are two conjugation machineries (Figure 1.4). One (System I, Figure 
1.4) begins with Atg? which activates Atg 10 to conjugate Atg5 with Atg 12. Atg 16 is 
assembled to the complex Atgl2-Atg5.
In the other system (System II, Figure 1.4) Atg? is activated and transfers AtgS, 
previously prepared by Atg4, to AtgS after the conjugation of AtgS to 
phosphatidylethanolamine (PE). The two complexes Atg 12-Atg5-Atg 16 and AtgS-PE 
localize at the initial autophagosomal membrane (PAS) for the formation of the 
autophagic vacuole {Yorimitsu, 2005 #118}.
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The proteins Atg 12 and Atg5 are implicated in the formation of the autophagosomal 
membrane but they are not present in the sealed autophagosome (Suzuki et al., 2001) 
(Kim et al., 2002). It is not know at present if a similar pathway and set of complexes 
is present in mammalian cells as well.
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Figure 1.4 The two Atg conjugation machinery in yeast
Most of the Atg proteins are conserved in mammals. The best analysed is ATG8 and 
the mammalian homolog of ATG8 is called microtubule associated protein 1 light 
chain 3, or LC3. LC3 plays a role in the formation of the autophagosome (Kabeya et 
al., 2000). LC3 is cytosolic but after processing by ATG7 it become membrane bound 
and localizes with the initial membrane and early autophagosomes similarly to the
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yeast system II process (Figure 1.4). During maturation of the early autophagosome 
the LC3 on the external membrane is cleaved off and the LC3 on the inner membrane 
stays trapped inside until rapidly degraded by the lysosomal hydrolases after lysosome 
fusion (Kabeya et al., 2000).
At present LC3 is the only marker available to label mature autophagic vacuoles. 
For this reason determination of the ultrastructural morphology of autophagy by 
electron microscopy is still a largely irreplaceable technique for the investigation of 
the autophagic pathway.
1 .4 .4  T he m am m alian  a u to p h a g ic  p a th w a y  is  a m uiti s t e p  p a th w ay  
in v o lv in g  fu s io n  e v e n t s  w ith  th e  e n d o c y t ic  p a th w ay
Autophagosomes have been reported to fuse with early endosomes (Liou et al., 
1997; Tooze et al., 1990), late endosomes (Lucocq and Walker, 1997) and lysosomes 
(Dunn, 1990b) suggesting that all the autophagic pathway is intimately connected to 
the endocytic one (Figure 1.5).
The limiting membrane of autophagosomes contains trace amounts of lysosomal 
markers indicating that these proteins are recruited during autophagosomal maturation 
(Tanaka et al., 2000) (Eskelinen et al., 2002).
The final step of the autophagic pathway is the fusion of the autophagosome with the 
lysosome, as the autophagosome requires the lyosomal hydrolases to degrade its 
engulfed material. While the maturation progresses the autophagosome acquires 
lysosomal markers including Rab7, Lamp I but loses LC3 (Jager et al., 2004)
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E n d o c y to s is
Figure 1.5 Endocytic and autophagic pathways are connected
EE (early endosomes), MVB (multivesicular bodies) and L (lysosomes) fuse with Avi 
(early autophagosomes) and Avl (late autophagosomes)
Intact microtubules are fundamental for autophagosomal maturation and their 
motility. Use of vinblastine or nocodazole, drugs that prevent polymerization of 
microtubules, induce accumulation of autophagosomes that do not contain hydrolases, 
suggesting a role for the microtubules in fusion of autophagosomes with lysosomes 
(Kochi et al., 2006).
pH seems to be important for fusion of autophagosomes with lysosomes; initially 
autophagosomes have the same pH as the surrounding cytoplasm, but during 
maturation their pH becomes acidic preceeding any delivery of the lysosomal enzymes 
(Dunn, 1990a) (Punnonen et al., 1992). Treatment with bafilomycin, an inhibitor of 
the lysosomal proton pump that maintains the lysosome at the optimal pH for 
lysosomal hydrolases to work, disrupts pH and stimulates accumulation of autophagic 
structures. This suggests that fusion between autophagosomes and lysosomes is 
inhibited by bafalomycin (Mousavi et al., 2001; Yamamoto et al., 1998) and that 
lysosomal pH plays a role in the fusion process.
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1 .4 .5  A u to p h a g y  an d  n e u r o d e g e n e r a tio n :  n eu ro n a l c e ll d ea th  or  
p r o te c tio n  a g a in s t  it?
Autophagic vacuoles have been noted in many neurodegenerative diseases such as 
Alzheimer and Parkinson (Nixon et al., 2005; Rubinsztein et a l , 2005), but their 
significance has still to be interpreted (Levine and Kroemer, 2008). Autophagy is a 
defence mechanism which can rescue the cells in starvation conditions, but 
morphological studies in neurons from patients affected by neurodegenerative diseases 
such as Alzheimer disease, showed an abnormal increase in number of 
autophagosomes (Nixon et al., 2005) (Yu et al., 2005). An autophagy related 
mechanism of cell death has been called programmed cell death type 11 (PCDIl).
PCDII differs from apoptotic programmed cell death (PCDl) because dying cells are 
full of autophagic vacuoles and they do not present with apoptotic features such as 
cytoskeleton collapse, cell shrinkage, membrane blebbing or cromatin condensation. 
Furthermore autophagy uses lysosomal enzymes and the dying cells employ the 
endogenous lysosomal machinery (Shintani and Klionsky, 2004).
In Alzheimer disease autophagosomes accumulate progressively to become the 
predominant organelle in neurons, their presence reflecting autophagy activation and 
the impaired maturation of autophagosomes to autophagolysosomes (Nixon et al., 
2005). Autophagy is also crucial in Huntington disease, where fusion between 
autophagosomes and lysosomes is impaired and increases aggregation of the 
Huntington protein in cells. Rapamacyin treatment which stimulates autophagy 
reduces htt accumulation and neurodegeneration in fly and mouse models for 
Huntington disease(Ravikumar et al., 2004).
The impairment of the maturation of autophagosomes to autolysosomes also leads to a 
continuous autophagic build up in Pompe disease (Fukuda et al., 2006).
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1.5 Phagocytosis
The characteristic accumulation of storage material observed in JNCL has been found 
in all cells of the body including microglia in the brain. Microglial cells, are 
scavengers cells that remove the damaged neurons by phagocytosis, in the Cln3 KO 
mouse they present a large accumulation of storage material which appears to be 
properly internalized by these cells, but not digested efficiently.
Phagocytosis is a receptor mediated process of professional phagocytic cells, such as 
neutrophils or macrophages and it is used for the elimination of foreign particles and 
apoptotic bodies(Vieira et al., 2002).
Phagocytosis is initiated by the clustering of surface receptors upon interaction with 
the relevant ligand. A well known family of phagocytosis receptors are the FcIIX 
Receptors (FcR) which bind to opsonized pathogens.
Newly formed phagosomes are relatively inert but as soon as the phagosomal 
membrane seals, interactions between phagosomes and endocytic components start, in 
a fashion that recapitulates the endocytic sequence (Vieira et al., 2002). The 
phagosomes initiate a dynamic fusing activity with repeated, transient fusion events in 
which they acquire endocytic markers allowing their maturation. This ultimately 
yields, after fusion with a lysosome, a phagolysosome (Tjelle et al., 2000).
Ten minutes after the fission of the phagosome from the PM, the phagosome has 
already acquired EEAl and Rab5 through kiss and run events with sorting endosomes 
(Duclos et al., 2000). Early fusion events involve the activity o f the type 111 P1-3K, 
which generates phosphatidylinositol 3-phosphate (PI3P) on the phagosomal 
membrane. Inhibitors of P1-3K activity were found to diminish EEAl recruitment to 
newly formed phagosomes and block phagosomal acquisition of late endocytic 
properties, indicating that generation of PI3P plays a role in phagosomal maturation 
(Fratti et al., 2001).
As expected, SNARE proteins also participate in phagosomal maturation; syntaxin 13 
at the initial stage and syntaxin 7 recruited later (Collins et al., 2002).
Twenty minutes after phagosomal sealing, the phagosome has lost all its early 
endocytic markers and acquired late endocytic markers such as Lampl and Rab?
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through fusion with lysosomes. Lampl and Lamp2 have recently been reported to be 
important for the complete maturation of the phagosomes (Huynh et al., 2007).
The connection between the phagocytic, endocytic and autophagic pathways is shown 
in Figure 1.6.
L^M Pl. LAMP2 
RAB7. SVNT13 
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Figure 1.6 Phagocytic, Endocytic and Autophagic pathways
EE indicate early endosomes, LE/L indicate late edosomes/lysosome.
1.5.1 M odified non p ro fess io n a l p h a g o cy tic  c e lls  a s  a sy s te m  to  
stu d y  p h a g o c y to s is
To study phagosomal maturation, a new approach has been used in recent years, where 
non-professional phagocytic cells are transfected with FcIIX, receptor, conferring 
phagocytic capability to those cells. Such cells are able not only to internalize 
phagosomes but these phagosomes can also mature by endocytic fusion(Downey et al., 
1999).
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It has been reported that cells such as COS cells or mouse embryonic fibroblasts, when 
transfected with Fell A,, are able to internalize latex beads opsonized with IgG via 
phagosomes and the beads acquire endocytic markers, allowing the study of the 
maturation o f the phagosomal membrane, by monitoring the phagosomal acquisition 
of endocytic proteins.
1.6 Mannose 6 phosphate receptor
JNCL is a lysosomal storage disease characterized by a prominant accumulation of 
undegraded material in lysosomes. Cells degrade their lysosomal content using 
lysosomal hydrolases, which arrive to the lysosomes by delivery via mannose 6 
phosphate receptors (MPRs).
Defective cathepsin D processing was already reported in cells from JNCL patients 
and ClnS mice models suggesting a defect in hydrolase processing (Golabek et al., 
2000; Fossale et al., 2004; Pohl et al., 2007). There is no published evidence yet that 
cathepsin D activity is deficient in CLN3 cells, and no-one has yet directly examined 
trafficking of this model. In order to examine this aspect of lysosome function, part of 
our investigation to determine the function o f CLN3 focused on trafficking of the 
mannose 6 phosphate receptor (Cl-MPR) which is responsible for delivery of 
lysosomal hydrolases to the lysosome.
1.6.1 CI-MPR a n d  CD-M PR
Soluble lysosomal hydrolases become postranslationally modified by the addition of 
mannose residues at the TGN where they are then recognized by the mannose 6- 
phosphate receptors for targeting to the lysosome(Kornfeld and Mellman, 1989).
In mammalian cells there are two types o f mannose 6 phosphate receptor, the 46-kDa 
cation independent mannose 6-phosphate receptor (CD-MPR) and the 300 k-Da cation 
dependent mannose 6-phosphate receptor (CI-MPR). Both receptors are type I
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transmembrane proteins and they are involved in targeting of lysosomal hydrolases to 
the lysosomes (Pohlmann et al., 1995).
The association between ligand (hydrolase) and receptor (CI-MPR) is fundamental to 
the delivery of the enzyme to the lysosome and prevents the secretion of the lysosomal 
enzymes.
A detailed study o f CI-MPR localization, done by electron microscopy analysing cryo- 
sections of HepG2 and BHK cells double transfected with CI-MPR and CD-MPR 
showed the presence o f both receptors in TGN, recycling early endosomes, plasma 
membrane, late endosomes, and endosomes with many vesicles. The CD-MPR 
appeared to be concentrated in the associated tubules and vesicles, whereas the CI- 
MPR was more prominent in the central vacuole of endosomes(Klumperman et al., 
1993). However both receptors have been found in the same coated buds at the TGN, 
suggesting that they use the same exit from the Golgi (Klumperman et al., 1993).
1 .6 .2  T he CI-MPR ro u te
The cycling o f mannose 6 phosphate receptor follows a complicated cellular itinerary 
(Figure 1.7).
Endocytosed CI-MPR is delivered to the TGN via transferrin positive recycling early 
endosomes (REC) but leaves this compartment very rapidly such that at steady state 
only a small fraction of CI-MPR stays in the REC (Lin et al., 2004).
CI-MPR binds its hydrolase cargo at the TGN and the complex is packaged into 
transport carriers that deliver the receptor with its ligand to the prelysosomal 
endosomes (Lin et al., 2004).
A cluster of amino acids followed by a dileucine motif in the cytoplasmic tail mediates 
receptor sorting from the TGN to late endosomes, since it has been shown that 
mutations in this motif prevents. Lysosomal enzyme sorting by blocking association 
of the CI-MPR with coat proteins in the TGN(Tortorella et al., 2007).
To maintain efficient sorting and transport of the hydrolases, as soon as the MPR 
dissociates from the ligand, it must be prevented from degradation in the lysosome and 
is sent back to the TGN for a new cycle. Tail interacting 47-kDa protein (TIP47) binds
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to the cytoplamic domains of both MPRs for this purpose and is required for their 
transport from endosomes to the TGN; it also binds to Rab9, increasing the affinity 
between TIP47 and CI-MPR. Rab9 positive vesicles have been visualized leaving the 
late endosomal compartment and fusing with the TON (Barbero et al., 2002).
There is also evidence that AP-1 and PACS-1 are involved in MPR recycling. In cells 
lacking either AP-1 or PACS-1, MPRs accumulate in endosomes indicating that these 
proteins can have a role in MPR trafficking from the endosomes to the Golgi(Meyer et 
al., 2000).
The retrieval of CI-MPR from the endosomes to the TGN is also reported to be 
retromer dependent. Cells lacking mammalian VPS26, which is normally localized 
with EEAl and Rab5, fail to retrieve CI-MPR resulting in its mislocalization at the 
PM and in early endosomes (Seaman, 2004).
CI-MPR but not CD-MPR is able to bind M6P-containing ligands at the PM. There 
are several ways by which the CI-MPR can reach the PM, one is via direct carriers 
from the TGN destined for the PM, another is by recycling from early endosomes/late 
endosomes (Riederer et al., 1994). Once at the cell surface the CI-MRP gets 
internalized rapidly.
1 .6 .3  CI-MPR e x it  from  th e  TGN
CI-MPR recognizes the mannose 6 phosphate groups attached to lysosomal hydrolases 
(Kornfeld, 1992). The receptor-ligand complex leaves the TGN segregated in tubulo- 
vesicular structures (Waguri et al., 2003) coated by clathrin (CCV) and the adaptor 
proteins AP-1 and GGAs.
The CI-MPR cytoplasmic cytosolic tail contains a dileucine motif that directs sorting 
from TGN to the endosome; it was thought that sorting of MPRs at the TGN was 
mediated by AP-1 but CI-MPR does not bind AP-1 with its dileucine motif (Honing et 
al., 1997). The CI-MPR cytosolic tail interacts with the VHS domain of the GGA 
proteins instead, as proved by yeast two hybrid system and GST pulldown assays 
(Puertollano et al., 2001). The overexpression of a dominant negative GGAl VHS-
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GAT domain caused accumulation of CD-MPR at the TGN suggesting that GGAs 
may be also required for CD-MPR exit from the TGN (Puertollano et al-, 2001).
The 3 cytosolic GGAs proteins are recruited from the cytoplasm to the TGN where 
they then colocalize in the same coated buds (Ghosh et al., 2003b). Individual GGAs 
are recruited as monomers from the cytosol onto the Golgi in an ARF-GTP dependent 
manner and then form a complex which interacts with AP-1.
GGAs may bind MPRs in the trans Golgi network and bring them to AP-1 containing 
clathrin coated vesicles. Overexpression of CD8-CI-MPR enhances GGA recruitment 
(Hirst et al., 2007).
Transported via 60-100nm CCVs, CI-MPR and GGAs rapidly uncoat and fuse with 
the prelysosomal endosomes, into which the cargo is released. The amount of AP-1 
bound to membranes and associated with clathrin-coated vesicles depends on the 
expression levels of MPRs (Le Borgne and Hoflack, 1997).
Dissociation o f the CI-MPR and cargo is caused by the acidic environment of the 
endosomes. However for CD-MPR it was recently showed that the capacity to deliver 
the cargo hydrolases to the lysosomes does not depend on endosomal acidification 
(Probst et a l, 2006).
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O
Figure 1.7 CI-MPR trafficking route
Aim of this thesis
The CLN3 protein was isolated as the cause of juvenile Batten disease or 
JNCL over ten years ago. However despite reasonably intensive efforts, the normal 
function of this protein and how this function is compromised by mutations to give 
rise to cellular dysfunction remains obscure. The laek of specific antisera that 
recognise the hydrophobic CLN3 protein, coupled with its low level ubiquitous 
expression, has made it difficult to arrive at a consensus on its intracellular location
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and topology and has halted attempts to determine its interaction partners. As for other 
NCLs, the exact nature and origin of the storage material in JNCL is uncertain so that 
unlike for many other lysosome storage disorders, analysis of the storage material has 
not proven useful in providing a hypothesis for the protein’s function, except 
suggesting a putative role for CLN3 in autophagy since the major protein stored is 
mitochondrial in origin.
The major aim of this study was to provide insight into the functional biology 
of the CLN3 protein in order to determine the molecular basis of juvenile Batten 
disease, starting from a characterisation of the cell biology of CLN3 deficient cells. 
With its cellular location and the nature of the disorder, the major focus was on 
investigating the primary endocytic and autophagic defects arising from the loss of the 
CLN3 protein. A study was made of early events associated with the loss of CLN3, 
using cells cultured from juvenile Batten disease patients and from the Cln3 knockout 
mouse model, in addition to siRNA-treated cell lines where CLN3 gene expression 
was silenced.
Chapter 3 presents a detailed ultrastructural analysis of the changes in 
morphology of human skin fibroblasts from JNCL cells and fibroblasts and neurons 
from the Cln3 KO mouse. Chapter 4 describes an extended investigation of the 
abnormal accumulation of autophagic structures that was detected in JNCL cells, 
aimed at understanding the reasons for this phenotype and the exact role of CLN3 in 
the autophagic pathway. It also includes work following on from this addressing the 
role o f CLN3 in the related phagocytic pathway. Chapter 5 presents work following 
from cellular immunofluorescence studies and the observation of an altered 
distribution o f the cation-independent mannose 6-phosphate receptor in JNCL cells. 
The nature of this apparent trafficking defect and the role CLN3 plays in governing 
correct function o f the lysosome via this critical lysosomal hydrolase receptor is 
investigated. Chapter 6 links defects in the autophagic pathway arising from 
dysfunction of CLN3 to alterations in the distribution of CI-MPR, exploring the
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connection between the trans Golgi network (TGN) and formation and maturation of 
autophagosomes.
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Materials and methods
2.1 Ceil culture
2.1.1 Cell l in e s  a n d  m a in te n a n c e
The cells lines used in the thesis are listed in Table 2-1.
All the cells lines used were grown in Dulbecco’s modified Eagle’s medium (DMEM, 
Gibco /Invitrogen,Paisley, UK) plus 10% fetal calf serum (Biowest, Miami, Florida) and 
in Nunc tissue culture plastic dishes (Gibco/Invitrogen (Paisley, UK) at 37 C° and 5% 
CO2
Fibroblasts were grown in 10 cm plastic dishes and maintained at 80% confluency 
judged by eye. Mouse fibroblasts were passaged at a ratio o f 1:2 and maintained for 
use to a maximum of three passages only. Human skin fibroblasts were passaged at a 
ratio of 1:2 and maintained for use to a maximum of 20 passages.
HeLa cells were maintained at almost full confluency and passaged at a ratio of 1:3.
43
Chapter 2 Materials and methods
Table 2-1 Cells lines used in this thesis
ID Overexpressed proteins Source
Human primary 1 Hs68 ECACC
fibroblasts 48BR Peter Clingen,UCL
from healthy 1BR.3
control AGO
(used as WT) J HF523N Elaine Aegius, Sara Mole,Uk
HF524N
HF526N
HF527N
HF528N
'  HF529N
Human primary 
fibroblasts 
from 1KB deletion 
JNCL patients
Mouse embryonic 
fibroblasts 
HeLa cells 
HeLa cells 
HeLa cells
I
I
HF 470Pa
HF478Pa
HF479Pa
HF480Pa
HF481Pa
CD8-CI-MPR
EGFP-LC3
GOS
Alfried Kohschutter,Germany
Hannah Mitchison
UCL, London
Alan Hall, Sloan Kett. NY
Aviva Toikovsky, Cambridge
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2 .1 .2  P rep a ra tio n  o f  m o u s e  em b r y o n ic  f ib r o b la s ts
Pregnant female mice at 13-14 days gestation were sacrified and embryos collected 
for dissection into phosphate-buffered saline (PBS) in a Petri dish. PBS consisted of 
8g NaCl, 0,2g of KCl, 1.44g of Na2HPÛ4, 0.24g of KH2PO4 per litre, pH adjusted to 
7.4. The head and viscera were removed from the embyos with forceps. The carcasses 
were plated in a fresh dish and minced, then the material was transferred into a 
solution of 0.25% trypsin (Gibco) in DMEM media (Gibco) in a 50 ml falcon tube, 2 
mis per embryo. This was incubated at 2>TC for 20 minutes, then triturated using a 5 
ml pipette in order to break up the tissues. The supernatant was transferred to a new 
tube and an equal volume of growth media (Dulbecco’s modified Eagle’s medium 
(DMEM, Gibco)) supplemented with 10% fetal calf serum (Bioline) was added. Cells 
were counted and plated out at a density of 10  ^cells (or 0.5 embryo) per 10 cm culture 
dish.
2 .1 .3  F reez in g  a n d  th a w in g  cu ltu red  c e l ls
Aliquots of 1x10^ cells were suspended in 1 ml of PCS supplemented with 10% 
DMSO. These were frozen overnight at -SO^ ’C. The aliquots were moved to liquid 
nitrogen for permanent storage. Individual aliquots were thawed rapidly at 37°C and 
placed in a 15cm dish with 25 ml pre-warmed medium.. Cells were then grown in 
fresh medium, and initially passaged two days post-thawing.
2 .1 .4  T ra n sien t tr a n s fe c t io n s
For transient transfection experiments, cells were grown to 80% confluency and 
transfected by nucleofection with DNA or siRNA construct using a nucleofector 
device from Amaxa Biosystems.
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Cell number, nucleofection program and DNA or siRNA concentration were used 
according to the nucleofection machine manufacturer’s instructions found in the 
human skin fibroblasts, mouse embryonic fibroblasts or HeLa cells kit (Table 2-2). 
Cells were grown for at least a further 24 hours before use in immunofluorescence or 
electron microscopy studies.
Constructs used in the thesis are listed in Table 2-3 for DNA constructs.
There are a number of different human CLN3 transcripts and therefore two 
oligonucleotides were designed to ensure the most complete gene knockdown. These 
were located in exon 6 and exon 10, both portions of the gene where all the CLN3 
transcripts overlapped and in Table 2-4 for siRNA sequences (supplied by MWG).
Table 2-2 Transient transfections details
Cell type Cell number Nucleofector
Program
DNA
Concentration
siRNA
Concentration
HeLa cells 1.10* A28 5 pg/^1 20pM
Human skin 
Fibroblasts
2.10* U23 3 M-g/p-1
Mouse Emb, 
Fibr.
2.10* T20 5
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Table 2-3 DNA constructs used in this thesis
Construct Source
CLN3-MYC Thomas Braulke, University of Hamburg
CLN3-EGFP Aija Kyttala, Biomedicum, University of Helsinki
CLN3-GFP Sara Mole, UCL, London
CI-MPR-CD8 Matthew Seaman, University of Cambridge
FcIIXReceptor Emmanuelle Caron, Imperial College, London
LC3-EGFP Tamotsu Yoshimori, Japan
RAB7-EGFP Cecilia Bucci, Italy
Table 2-4 Details of siRNA oligos used in this thesis
Target/siRNA mRNA target sequence
CLN3 1 (exon 6) GUGGGAUUUGUGCUGCUGGAA
CLN3 2 (exon 10) CCAGCCUCUCCCUUCGGGAAA
Scrambl ed/ contro 1 AAUUCUCCGAACGUGUCACGU
2 .1 .5  S ta rv a tio n
To obtain starvation conditions, cells were washed in PBS and incubated in Earl’s salt 
balanced medium (BBSS) at 37 C  and 5% CO2 for different time periods.
2 .1 .6  P rep aration  o f  CD8-CI-M PR s ta b le  c e ll l in e s
HeLa cells were transfected with CD8-CI-MPR using an Amaxa nucleofector device 
and grown in presence of 1:200 concentration G418 (Calbiochem -  3451812) until
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mocks mostly dead. Cells were then splitted hard into 15cm dishes (1:10,000) to allow 
single colonies to be isolated.
Approximately 1 week later, trypsin soaked filter papers were placed onto the single 
colonies. Filter papers were transferred into 24 well format dishes. One clone (colony) 
per well and grown up until in 10 or 15cm well format (approximately 1 0 -1 4  days). 
Positive clones for CD8-CI-MPR were assessed by immunofluoescence:
2 .2  FACS analysis
Cells were washed in PBS after removal of the growing medium, lifted in PBS 5mM 
EDTA and collected in a 10ml falcon tube. Subsequently cells were spun down at 
1200rpm and the PBS 5mM EDTA removed. The cell pellet was resuspended in 100 
pm FACS incubation buffer (PBS, 5% FCS and 0.1% azide), spun down again and 
resuspended in 100 pM FACS incubation buffer with secondary antibody. Cells were 
then incubated on ice for 30 minutes and after that spun down and resuspended in 
FACS fix (4% paraformaldheyde in PBS).
Quantitative analysis of fluorescence intensity was carried out using a FACSCalibur 
flow cytometer with 10,000 gated events analyzed. The relative fluorescence was 
determined by comparing HeLa cells expressing GFP (positive control) transfected 24 
hours before the experiment against untreated HeLa cells (negative control).
2.3 Immunofluorescence microscopy
2.3 .1  Ind irect im m u n o f lu o r e s c e n c e
Cells were grown on 30mm diameter glass coverslips (VWR International) for 
immunofluorescence studies.
The coverslips with the adherent cells were washed in PBS and then fixed in 4% 
paraformaldehyde in PBS for 15 minutes at room temperature followed by
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permeabilization with 0.1% saponin. Free aldehyde groups were then quenched with 
50mM ammonium chloride in PBS for 15 minutes.
Subsequently the cells were labelled for 60 minutes with primary antibody in PGAS 
blocking buffer ( 0.01% saponin, 0.1% gelatin in PBS).
Detection was by secondary antibodies in PGAS for 45 minutes.
Primary and secondary antibodies used in this thesis are listed in Table 2-7.
Finally, the coverslips were washed again 3 times quickly in PBS and once in distilled 
water, mounted with Prolong antifade mountant (Molecular Probes) and viewed on a 
confocal scanner microscope MRC1024 or confocol microscope Leica SPE.
2.4 Phagocytosis assay
Cells were transfected with the Fc receptor construct using an Amaxa nucleofector 
device. After 24 hours cells were incubated in serum free media for various time 
points with 3 pM latex beads that had previously been opsonized with human IgG 
(overnight, rotating on ice in human serum). The phagocytosis was synchronized by 
spinning down the cells for 1 minute at 1400 rpm after addition of beads.
At the end of the time point, cells were stained, for 10 minutes on ice with secondary 
antibody against human anti IgG to stain all the external beads, then 4% PFA fixed 
and stained with secondary antibody anti human IgG (of a different fluorophore from 
the one used to label just the external beads) to label all the beads.
2.5 Molecuiar biology
2.5.1 T ran sform ation  o f  E .co //
Chemically competent cells (DH5a strain, Invitrogen, UK) were thawed quickly at 
room temperature and placed on ice. DNA constructs (1 pi of plasmids for 
amplification) to be transformed were placed in 1.5 ml microfuge tubes and mixed 
with 50 pi competent cell suspension. Tubes were tapped and placed on ice for 5 min.
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Cells were ‘heat shocked’ by incubation at 42°C for 45 sec and were then immediately 
returned to ice for 5 min. Pre-warmed L-Broth (200 pi per transformation) was added 
and the cells were incubated with moderate agitation for 10 min (amplification). 200 
pi of transformed bacteria were plated onto selective LB agar plates containing either 
ampicillin (50 pg/ml) or kanamycin (30 pg/ml) as required. Plates were incubated 
overnight at 37°C.
2 .5 .2  B acteria l DNA m axi prep
DNA was prepared using GenElute HP Plasmid Maxiprep Kit ® (Sigma) according to 
the manufacturers instructions. Elution of DNA was followed by an Ethanol 
precipitation. 500 pi of 3M NaOAc, pH 5.2 and 12.5 ml of 100% ice-cold EtOH were 
added to the 5 ml eluate. Tubes were centrifuged at 3400 x g for 30 min at 4°C. 
Supernatants were discarded and pellets were resuspended in 1 ml 70% ice-cold EtOH. 
After centrifugation at 5000 x g for 10 min, the supernatants were carefully discarded. 
Pellets were left to air dry and resuspended in 500 pi -  1 ml distilled water.
2 .5 .3  P o ly m e r a s e  ch a in  rea ctio n
DNA was amplified in a thermocycler. PCR reactions used a final volume of 20 pi 
containing 10 ng template DNA, 50pM dNTPs (Promega), 0.25 pi Taq polymerase 
(Promega) when testing for HeLa specific expression, or 0.25pl Pfu polymerase 
(Promega) for cloning, plus 20pM of each oligonucleotide primer (Invitrogen) and 2pl 
of the respective polymerase lOx buffer. DNA was amplified using reaction specific 
programmes with the following parameters; Ix at 95°C for 5 min, 30-35x [95°C for 1 
min, 55-65°C for 1 min, 72°C for 1 to 3 min, depending on the length of product] and 
Ix 72°C for 10 min. PCR products were purified for cloning using the QIAquick® 
PCR Purification Kit (Qiagen) according to the manufacturers instructions.
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2 .5 .4  RNA ex tr a c tio n
Cell were lysed in lysis buffer, plus p mercaptoethanol, included in the Qiagen 
RNeasy mini kit. The lysates were homogenised using the Qiashredder and then 
processed according to manufacturers instructions for the Qiagen RNeasy mini kit. 
RNA was eluted in 30^il of RNase free water.
2 .5 .5  R e v e r s e  tra n scr ip tio n
RNA was reverse transcribed using the Superscript™ III First-Strand Synthesis 
System for RT-PCR (Invitrogen). lOpj of RNA was used for each reaction and 
random hexamers were used as primers in this reaction to ensure total DNA 
amplification. Incubation times were according to manufacturers instruction.
2 .5 .6  DNA q u a n tita tio n
The concentration and purity of DNA preparations were examined by optical density 
(AbS260/280)'
2 .5 .7  R eal t im e  PCR
DyNAmo™ SYBR® Green qPCR Kit was used to quantify the relative amount of 
DNA in the various samples. This kit is composed of a master mix containing 
modified Thermus brockianus DNA Polymerase, SYBR Green I dye, optimized PCR 
buffer, 5mM MgCb, dNTP mix including dUTP. Added to this were the gene specific 
primers either at 1.2p,M or IX final concentration for the Quantitect primers (Quagen) 
and the DNA samples, which were diluted to 150ng/(Lil. The sequences of the primers 
are set out in Table 2-5 and the cycling conditions in Table 2-6. All primers were 
designed to produce a product that encompasses two exons to ensure that no genomic
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DNA contaminated the cDNA preparations and the amplicons were 100-200 base 
pairs.
Table 2-5 Primers used in the real time PCR
Target Sequence
CLN3 QuiagenHs_CLN3_l_SGQuantiTectPrimerAssay(NM_000086)
Actin forward: GCGAGAAGATGACCCAGAT
reverse: TGGTGGTGAAGCTGTAGCC
Table 2-6 Cycling conditions used for the real time PCR
Step # Purpose Temperature Time
1 Initial dénaturation 95°C
2 Dénaturation 94 °C
3 Annealing 55°C
4 Extension 72°C
5 Fluorescence measurement 72^'C and 77°C 
Steps number 2-5 are repeated 39 times
6 Final extension 72°C
1 Melting curve 72°C -95
8 Reannealing 72 °C
10 mins 
10 secs 
15 secs 
20 secs 
1 see each
8 mins
approx. 20 mins 
8 mins
The melting curve was used to check the specificity of the amplified product. Primers 
that formed more than one product were discarded. The relative knockdown for each
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product was determined by comparing the cycle number at which the amount of PCR 
product exponentially increases (C(t)) between knockdown and mock transfected 
cDNA sample using the method (Livak and Schmittgen, 2001).
AC(t) gene specific = knockdown C(t) -  mock C(t)
AC(t) housekeeping = knockdown C(t) -  mock C(t)
AAC(t) = AC(t) gene specific - AC(t) housekeeping
In all siRNA experiments, <90% knock down of CLN3 expression was confirmed 
using the exon 6 and exon 10 siRNAs together by real time PCR.
2 .6  Antibodies
Details of all the primary antibodies used in this thesis are presented in Table 2-7. 
Details of all the secondary antibodies used in this thesis are presented in Table 2-8.
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Table 2-7 Primary antibody used in this thesis
Antibody Species/Isotype Source
CathepsinD Mouse (CTD-19) Abeam
CD8 Mouse Matthew Seaman, Cambridge
CD8 Mouse (UCHT4) Ancell
CI-MPR Rabbit Peter Loebel
LC3 Mouse Yoshimori, Japan
EEAl Mouse BD Transduction laboratories
GFP Rabbit LMCB, EM unit
HRP Rabbit (BO 144) DAKO
Lampl Mouse (H4A3) Developmental studies Hybridoma Bank
Lampl Rat (CD 107a) PharMingen
Lampl Rabbit (abl9294) Abeam
LBPA Mouse Juan Gruenberg
LC3 Rabbit Yoshimori, Japan
Lgpl20 Rabbit Colin Hopkins, Imperial
Myc Rabbit (sc-789) Santa Cruz bioteehlogy
R abll Rabbit (71-5300) Zymed laboratories (Invitrogen)
TGN46 Sheep (AHP500) AbD SEROTEC
Syntaxin 8 Mouse Andrew Peden, Cambridge
Subunit c Rabbit Eiki Kominami, Japan
Transferrin Rec. Mouse (H68.4) Zymed laboratories (Invitrogen)
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Table 2-8 secondary antibody used in this thesis
Antibody Source
Donkey a Mouse Alexa Fluor® 488 ’ 
Donkey a Mouse Alexa Fluor® 594 
Donkey a Sheep Alexa Fluor® 594
1
Invitrogen/Molecular Probes
Donkey a Sheep Alexa Fluor® 488
Donkey a Rabbit Alexa Fluor® 488 
Donkey a Rabbit Alexa Fluor® 594
Donkey a Mouse Cy5 \
Donkey a Sheep Cy5 Jackson Laboratories
Donkey a Rabbit Cy5
2.7 Electron microscopy
Electron microscopy samples were analyzed with a G2 Spirit transmission electron 
microscope and SIS Morada CCD camera.
2.7.1 Sample preparation for conventional electron microscopy
Cells were grown in glass coverslips to subconfluency and fixed in 2% 
paraformaldehyde and 1.5% gluteraldehyde, both reagents from TAAB Laboratories 
(Aldermaston, Berks, UK) and Agar Scientific (Stanstead, UK) in O.IM sodium 
cacodylate buffer for 2 0  minutes at room temperature after being washed briefly in 
PBS. Cell were subsequently briefly washed in sodium cacodylate buffer O.IM, pH 7.6
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and postfixed in 1% osmium tetroxide and 1.5% potassium ferrocyanide for one hour 
at 4C and then washed again in sodium cacodylate buffer O.IM.
The coverslips were incubated in 1% tannic acid in 0.05M sodium cacodylate, 
washed in sodium sulphate for 5 minutes and finally rinsed in water to start the 
process of dehydration by serial incubations of 5 minutes, twice each in 70% ethanol, 
90% ethanol and 100% ethanol. The coverslips were then immersed in a mixture of 
1:1 propylene oxide and Epon 812 for 1 hour, which was then replaced with 100% 
Epon to continue the embedding. The epon was changed twice in 4 hours and the 
coverslips were mounted in previously hardened blocks and baked overnight in an 
oven at 60 degrees.
The following day, the coverslips were detached from the block by immersion in 
liquid nitrogen and the cells were cut in ultra-thin sections on an Ultracut (UCT) 
ultramicrotome (Leica Microsystems, Vienna, Austria) at room temperature and stained 
with lead citrate.
2.7.1.1 Epon composition for sample embedding
TAAB 812 19.2 ml 
DDSA 7.6 ml 
MNA 13.2 ml 
DMP-30 0.8 ml
2.7.2 Horseradish peroxidase (HRP) feeding
Cells grown on glass coverslips were incubated for 90 minutes in Horseradish 
peroxidise (HRP, Type V, Sigma) at a concentration of 4mg/ml. The medium with 
HRP was then replaced with 2% paraformaldehyde and 1.5%glutaraldehyde fixative, 
and the location of the HRP was revealed by addition of diaminobenzidine and 
hydrogen peroxide.
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Then cells were postfixed with Osmium tetroxide and processed for electron 
microscopy as described above.
2.7.3 Coupling of Zenon® Fab fragments to the CDS antibody for 
electron microscopy study
The Zenon mouse IgGza labelling kit (Molecular Probes) was used to conjugate the 
CD8  antibody to HRP-Fab fragments.
HRP enzymes previously conjugated to Fab fragments were provided in the Zenon® 
molecular labelling kit. 1 pg of the CD8  antibody was added to 5 pi of the Zenon® 
mouse IgG2a labelling reagent for 5 minutes; after which 5 pi of the non isotype 
specific Zenon® blocking reagent was added to the reaction mixture for a further 5 
minutes according manufacture instructions.
The ready for use complex was added to 30 pi of media and used in feeding to allow 
internalization in the cells.
Figure 2.1 Zenon labeling kit
The Zenon labeling scheme. An unlabeled IgG is incubated with the Zenon labeling 
reagent, which contains an HRP-labeled Fab fragment (A). The labelled Fab fragment 
binds to the Fc portion of the IgG antibody (B), and excess Fab fragment is neutralized 
by the addition of a nonspecific IgG (C). The addition of nonspecific IgG prevents 
cross-labeling of the Fab fragment in experiments where multiple primary antibodies 
of the same type are present.
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Unlabeled 
IgG antibody
Incubate 1
B
Labeled Fab fragments 
bound to the IgG #
Zenon labeling reagent 
(labeled Fab fragment)
h Mix with non specific IgG, which complexes unbound Fab fragments
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2.7.4 Ultrathin cryosections (Tokuyasu technique)
2.7.4.1 Preparation of grids
EM grids were cleaned with 25% NH4OH in double distilled H 20 and dried on filter 
paper at 37°C. The grids were subsequently coated with a formvar film (1.1% (w/v) 
formvar in chloroform) and a very thin layer of carbon.
2.7.4.2 Sample embedding in gelatin
A monolayer of growing cells was fixed with 4% paraformaldehyde and 0.2% 
gluteraldehyde in O.IM phosphate buffer pH 7.4 for 1.5 hours at room temperature and 
subsequently scraped in 1% gelatine in PBS (provided by the Cell Microscopy Centre, 
University Medical Centre Utrecht, The Netherlands). Cells were embedded in 12% 
gelatin, infused in 2.3M sucrose and frozen in liquid nitrogen.
2.7.4.3 Immuno-goid labelling of ultra-thin cryosections
For labelling of ultra-thin cryosections, grids were first incubated in 2% gelatin in 
order to remove the methyl cellulose/sucrose mixture from the pick up solution. 
Sections were incubated on drops for 4 x 1 minute in 0.1% glycine in PBS to quench 
free aldehyde groups, and non-specific sites were blocked with 1% bovine serum 
albumine (BSA) in PBS for 3 minutes. The sections were labelled with primary 
antibody diluted in 1%BSA/PBS for 60 minutes, rinsed for 4 x 2 minutes with PBS 
and incubated for 20 minutes with Protein A-colloid gold (PAG) conjugates in 1% 
BSA/PBS (15nm, Cell Microscopy centre, Utrecht, the Netherlands) PAG. Unbound 
PAG was removed by washing with PBS.
Labelling was stabilised by fixing with 1% Gluteraldehyde in PBS for 5 minutes. 
After 1 0 x 1  minute washes, sections were stained with 2% uranyl oxalate/acetate at
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pH 7 for 5 minutes. The sections were rinsed in ice-cold ddH20 and incubated for 5 
minutes in 1% methyl cellulose/2% uranyl acetate pH 4 on ice. Finally, grids were 
picked up with loops and dried at RT to form a thin support film of methylcellulose 
and uranyl acetate.
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3 CLN3 is associated  with defective autophagy
Juvenile Batten disease is caused by mutations in the CLN3 protein, which is over 
90% of the cases is a Ikb deletion. The disease is characterized by the accumulation of 
subunit c of the mitochondrial ATPase in all the cells of the body. Previous work 
indicated that the storage material accumulates in lysosomes and it has a typical 
fingerprint aspect at the ultrastructural level.
CLN3 is a very hydrophobic protein which interacts with AP-1 and AP-3 to be 
targeted to the lysosomes. It was reported that CLN3 could traffic also via the PM. 
Much of the functional work done on CLN3 originates from the yeast S.cerevisiae 
model and a link was made between the protein causing JNCL and intracellular 
protein trafficking (Chattopadhyay et al., 2003; Fossale et al., 2004; Gachet et al., 
2005; Luiro et al., 2004).
The relationship between accumulation of storage material and lysosomal dysfunction 
is not clear.
In this chapter we investigated the CLN3 localization at the ultrastructural level and 
we attempted to discover the basic phentypes arising from CLN3 deficiency using 
fibroblasts and neuron cultures from the ClnS KO mouse and fibroblast cultures 
derived from JNCL patients with the Ikb deletion. The aim was to discover the early 
disease events from cells in culture for the first time in this laboratory, in order to gain 
an insight into the intracellular pathways distributed by CLN3 dysfunction. This work 
would form the basis of the follow-on research into the trafficking and degradation 
pathways described in subsequent chapters of the thesis.
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3.1 CLN3 localization: Immunogold labelling o f ultra-thin 
cryosections
Several groups have studied the localization of the CLN3 protein with varying 
results and the current best evidence is that CLN3 traffics through the ER and Golgi to 
the late endosomes and lysosomes (Haskell et ah, 2000; Jarvela et ah, 1998; Kida et 
ah, 1999) (Ezaki et ah, 2003) (Mao et ah, 2003a). This is governed by two lysosomal 
targeting motifs (Kyttala et ah, 2004; Storch et ah, 2004). A C terminal prénylation 
motif is also required for efficient sorting to lysosomes (Storch et ah, 2007). The 
CLN3 dileucine lysosome targeting motif binds to the adaptor complexes AP-1 and 
AP-3, suggesting that CLN3 can traffic through the plasma membrane and early 
endosomes even if  the final destination is the lysosomes (Kyttala et ah, 2005). This 
study was contested by another group, which found that CLN3 does not interact with 
AP-1, AP-3 or GGA3 adaptors (Storch et ah, 2004). Localisation experiments reported 
so far have used overexpressed CLN3 since no antibody directed against the 
endogenous CLN3 has been successfully raised.
To obtain more details on the compartment in which CLN3 resides, HeLa cells were 
transfected with CLN3-GFP using an Amaxa nucleofector device, fixed 24 hours later 
and prepared for cryo sectioning. Immunolabeling of ultra-thin cryosections (70 nm) 
was carried out using a GFP antibody to detect CLN3 followed by protein A gold, size 
1 0  nm (PAGio).
As expected, CLN3 labelled the late endosomal and lysosomal population (Figure 
3.1).
Representative cryosections from CLN3-GFP transfected HeLa cells are shown in 
Figure 3.2. Surprisingly, the CLN3 protein was also detected in endosomes containing 
multiple vesicles (panel A, B, E and F) and small vesicles of 30-40nm (panel B, C and 
E and Figure 3.1.) usually close to the plasma membrane. The endosomes with 
vesicles cannot be considered to be multivesicular bodies (MVBs) since the diameter 
of the structures where CLN3 is detected is below 200 nm and MVBs are usually 
around SOOnm.
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Figure 3.1 Ultra-thin cryosections Immunogold-iabelled for CLN3
HeLa cells transfected with CLN3-GFP , 24 hours later 4% PEA fixed and cryo- 
sectioned then labelled with GFP. This image shows the Golgi area with CLN3 
positive small vesicles (*), and a late endosome/lysosome (L).
Scale bar=500nm.
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Figure 3.2 Ultra-thin cryosections immunogold-iabelled for CLN3
HeLa cells were transfected with CLN3-GFP and 24 hours later 4% PFA fixed and 
cryo-sectioned then labelled with anti-GFP antibody. PM=plasma membrane. 
Arrow head= endosomes with few vesicles; * vesicles of 30-40 nm diameter.
Scale bar=200nm.
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3-2 Phenotypes arising from CLN3 deficiency
The strategy employed to search for basic phenotypes arising from loss of CLN3 
function was to investigate the integrity, organization and distribution of cellular 
organelles by immunofluorescence analysis using various organelles markers. This 
screening was done in parallel with ultrastructural analysis performed using electron 
microscopy.
The cells used for this study were fibroblasts from the Cln3 mice (referred to 
below as Cln3 KO) and primary skin fibroblasts from JNCL patients homozygous for 
the common CLN3 1 kb deletion carried on >80% of cases.
3.2.1 Cellular organelle survey in primary fibroblasts cultured from 
JNCL homozygous 1.02 Kb deletion patients
To examine the role of CLN3 in cellular trafficking, immunofluorescence studies were 
performed to determine whether deficiency in the CLN3 protein impaired the 
localization of the markers listed in Table 3-1. Control and 1 kb deletion human 
fibroblasts were grown for not more than 2 0  passages and analysed by indirect 
immunofluorescence.
Cells were fixed and labelled with antibodies for ER, Golgi, early endosomes, late 
endosomes and lysosomes, recycling early endosomes and the autophagosomal marker 
LC3.
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Table 3-1 Organelle markers used for human and mouse IF study
Organelle Antibodies
Lysosomes and late endosomes 
Recycling early endosomes 
Early endosomes 
Golgi 
ER
Autophagosome
Lampl (Lgpl20), CD63, Rab7, CI-MPR 
Rabl 1, Rab4, Transferrin receptor 
EEAl, Rab5
TGN46,TGN38, CI-MPR
Calreticulin
LC3
Staining with the endosomal, lysosomal (Figure 3.3) Golgi and ER markers (data not 
shown) did not reveal any morphological differences between wild type and mutant 
fibroblasts.
H
09
lgp l20 CD63
Figure 3.3 Immunofluorescence labelling of human skin fibroblasts from control 
and Ikb deletion patient for late endosomes/lysosomes
Control (panel A) and Ikb deletion JNCL (panel B) fibroblasts were fixed and 
immunolabelled for the late endosomal/lysosomal markers Lgpl20 and CD63.
Scale bar=10pm
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However a change was detected in the distribution of Rabl 1, Rabl 1 labelling showed 
a distinct difference in distribution between control and JNCL cells. In the mutant 
cells, Rabll localization was accentuated in the perinuclear area in contrast with 
control cells, in which it was also distributed in peripheral endosomes (Figure 3.4).
In addition to these differences, the microtubular associated protein light chain III 
(LC3), which is an autophagosomal marker also displayed an altered localization in 
JNCL cells.
LC3 is a cytoplasmic protein, which gets recruited to the autophagic membranes 
during the autophagosomal maturation (Kabeya et al., 2000). In the wild type cells, the 
LC3 staining was mostly dispersed in cytoplasm and only occasionally appeared to be 
associated with punctate vesicles, which represent autophagosomes (Figure 3.5, first 
panel).
In JNCL, there was a stronger staining for LC3 and it appeared to be associated mostly 
to punctate vesicles, which were dispersed throughout the cytoplasm. This suggested 
that the autophagic pathway could be upregulated (Figure 3.5, second panel).
WT 1KB
Figure 3.4 Immunofluorescence labelling of human skin fibroblasts from control 
and Ikb deletion patient for the early endosomal/recycling early endosome 
marker R abll
Control (panel on the left) and Ikb deletion JNCL (panel on the right) fibroblasts were 
fixed and immunolabelled for the early endosomal/recycling early endosomal marker 
Rabl I.
Scale bar=10pm
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Figure 3.5 Immunofluorescence labelling of human skin flbroblasts from control 
and Ikb deletion patient for the autophagosomal marker LC3
Control (panel on the left) and Ikb deletion JNCL (panel on the right) fibroblasts were 
fixed and immunolabelled for the autophagosomal marker LC3.
Scale bar=10pm
3.2.2 Ultrastructural examination of JNCL 1 kb deletion fibroblasts
Since JNCL human skin fibroblasts showed defects in distribution of certain endocytic 
and autophagic markers used in the screening performed at the light level, we decided 
to extended the study to include an investigation of the cellular architecture of the 
JNCL Ikb deletion fibroblasts by morphological ultrastructural analysis.
Cells passaged not more than 20 times were grown on glass coverslips, fixed and 
processed for electron microscopy examination. A detailed survey of cellular organelle 
showed no differences. Lysosomes, endosomes, ER, Golgi and mitochondria were 
morphologically normal in JNCL fibroblasts. Since CLN3 is a late 
endosomal/lysosomal protein, careful attention was given to the lysosomes in 
particular. Panel A and panel B of Figure 3.6 shows wild type lysosomes, which are 
between 500 to 700 nm, electron dense and contain membrane whorls.
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Figure 3.6 Electron micrographs of lysosomes from wild type human skin 
fibroblasts
Lysosomes are indicated by arrows 
Scale bar=500nm
The lysosomes of the control human skin fibroblasts have the same appearance as 
those from a JNCL patient as shown in Figure 3.7, panel B. However in the JNCL 
fibroblasts, two additional organelle compartments were also observed. As shown in 
panels A and C (large arrow heads) of Figure 3.8, the first of these consist of 
organelles, which morphologically can be identified as components of the endocytic 
pathway. The shape of these organelles is more elongated than conventional 
endosomes and their internal structure is composed of 2  different contents suggesting 
that they are organelles in the process of fusing.
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Figure 3,7 Electron micrographs of JNCL fibroblasts
The arrows indicates lysosomes. Large arrowhead indicates elongated endosomes. The 
small arrow head in A indicates an early autophagosome. Scale bar=500nm
The second and more expanded compartment consists of autophagosomes ( Figure 3.7, 
small arrow heads). Examined in more detail early autophagosomes (Figure 3.8 panels 
A, B, C, E) were clearly identified by the classic double membrane (small arrow 
heads) which surrounds the organelles, and the still distinguishable cytoplasmic 
content indicative of a newly formed organelle. Newly forming phagophores were 
visible in the perinuclear area, in the process of entrapping cytoplasm (Figure 3.8,
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panel B). In a representative example, close to one phagophore is another 
autophagosome but in a more advanced stage, as suggested by the increase in the 
electron density of this organelle (panel B). Many late autophagosomes were seen 
(panel B,D,F).
Early autophagosomes were often found in the vicinity of the late autophagosomes, 
and they were also most often positioned in the proximity of the Golgi area. More 
examples of autophagosomes are shown in the panels D and F of Figure 3.8.
As described in the section 3.2.1, the LC3 marker in mutated fibroblasts was 
prevalently associated with membranes rather then being mostly cytoplasmic as in WT 
cells, suggesting an accumulation of autophagic structures. EM analysis supports this 
finding, since it is immediately obvious that there is an enlargement of the autophagic 
compartment.
The morphologieal study illustrated so far was based on cell lines from one healthy 
individual (cell line called 1BR.3) and one Ikb JNCL patient (cell line called 
HF480Pa). To confirm the phenotype identified in the patient cell we carried out an 
analysis of additional cells lines derived from nine healthy individuals (cells lines 
called: 48BR, Hs6 8 , AGO, HF523N-HF529N) and four other JNCL patients with the 
same common Ikb deletion (cell lines called HF470Pa, HF478Pa, HF479Pa, 
HF481Pa). Detailed electron microscopy examination using these additional samples 
provided evidence of major differences between fibroblast cell lines. Accumulation of 
autophagic structures was again observed uniquely in the new mutant cell lines and 
not controls, but a big heterogenity was detected in the new control cell lines. 
Morphologically most of the new cells lines (patient and controls) were different from 
each other. The endocytic pathway in particular presented major differences, some of 
the cells lines in fact presented an expanded lysosomal compartment with granular 
features.
Clearly there could be heterogeneity of the cell types in the primary skin cultures, and 
their cell cycle stages. The differences between cell lines could also be due to the 
provenance of the cells, differences between individuals and the methods of culturing 
the cells at the initial passages in different labs. Due to the difficulty of working with
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Figure 3.8 Electron microscopy investigation of autophagic compartment in 
JNCL human skin Fibroblasts
Early autophagosomes are indicated by arrowheads, late autophagosomes are labelled 
AVI. Late endosomes are labelled (LE) and lysosomes (L) were also found.
In panel B there is an enlargement of the phagophore represented in the centre of panel 
A. Scale bar=0.5 pm.
72
Chapter 3 CLN3 is associated with defective autophagy
heterogeneous cell lines originating from different individuals and labs, the use of 
human skin fibroblasts was discontinued.
3.2.3 Survey of cellular organelles in CLN3 KO mouse primary 
fibroblasts (MEFs)
In parallel to the study in human skin fibroblasts described in 3.2.1, a survey was 
carried out using the same main organelle markers listed in Table 3-1 in mouse 
embryonic fibroblasts (MEFs) from wild type (WT) and Cln3 knock out mice (KO). 
Similarly to the findings for the human skin fibroblasts, few organelles appeared to be 
distributed differently in the wild type MEFs compared to the knock out MEFs. 
However some differences were observed, as follows.
The CI-MPR appeared to be present almost exclusively in the perinuclear region in the 
KG MEFs whereas in the WT MEFs it was also present in peripheral endosomes 
(Figure 3.9).
The early endosomal/recycling endosomal marker Rabl 1 was concentrated 
predominantly in the perinuclear region in the knock out MEFs whereas in the WT 
cells it was also observed in the peripherial endosomes (Figure 3.10).
WT CLX3 KO
0
Figure 3.9 CI-MPR labelling of WT and CLN3 KO mouse embryonic fibroblasts.
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Control (panel A) and CLN3 KO fibroblasts (panel B) were fixed and immunolabelled 
for the CI-MPR marker.
Scale bar=10 pm
WT C LN3 KO
Figure 3.10 Indirect immunofluorescence of MEFs with Rabll
Control (panel on the left) and CLN3 KG (panel on the right) fibroblasts were fixed 
and immunolabelled for the early endosomal/recycling early endosomal marker 
R abll.
Scale bar=10 pm
Similarly to the findings for human skin fibroblasts, no differences were observed in 
the KO MEFs for LAMPl or any other lysosomal marker used (Figure 3.11 and not 
shown). Surprisingly no difference was observed with the Cathepsin D antibody, 
which was reported to be more perinuclear in the cerebellar cells from the ClnS 
(Fossale et al., 2004).
Similarly to the Ikb JNCL fibroblasts, in the ClnS KO MEFs the autophagosomal 
marker LC3 stained the cell more strongly and was heavily concentrated in vesicles 
suggesting that autophagosomes accumulate in the KO cells (Figure 3.12) whereas in 
the WT it appeared to be more distributed in the cytoplasm.
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Figure 3.11 Indirect immunofluorescence of MEFs with the markers Lampl and 
Cathepsin D.
Control (panel A) and CLN3 KO (panel B) fibroblasts were fixed and immunolabelled 
for the late endosomal/lysosomal marker LAMPl and for the lysosomal hydrolase 
Cathepsin D.
Scale bar=10pm
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Figure 3.12 Indirect immunofluoresce of MEFs with the autophagosomal marker 
LC3. Control (both pictures, panel A) and CLN3 KO (both pictures, panel B) 
fibroblasts were fixed and immunolabelled for the autophagosomal marker LC3. Scale 
bar=10p,m
3.2.4 Ultrastructural examination of CLN3 KO mouse primary 
fibrobiasts (MEFs)
Wild type and Cln3 knock out MEFs were grown for not more than four passages, 
fixed, embedded for electron microscopy and analyzed.
The ultrastructural morphology of the cellular organelles was carefully examined and 
wild type cells were compared with the KO cells. No differences were detected 
between KO cells and WT cells except for the presence of an abnormal compartment, 
present exclusively in the KO MEFs.
The compartment consisted of organelles over lOOOnm in diameter, with internal 
membrane whorls and occasionally vesicles (Figure 3.13). Normal lysosomes were 
also present in the KO cells.
The organelles were autophagic in morphology containing partially or more 
completely degraded cytosolic material and organelles, suggesting they are part of an 
expanded autophagic population. The EM images were indicative of a malfunctioning 
autophagic pathway, similarly to that observed for the patient human skin fibroblasts 
in section 3.2.2.
The autophagic organelles in the KO MEFs were markedly bigger than any seen in the 
human skin fibroblasts. Most of them were observed to be in an advanced stage of 
maturation since the content was electron dense.
Early autophagic organelles were also found, but it was not possible to observe any 
cytoplasm as content (Figure 3.14).
Similarly to the human skin fibroblasts, no mitochondrial defects were observed. 
During the course of this study, two reports were published suggesting such defects in 
neuronal cells derived from the mice models (Fossale et ah, 2004; Luiro et ah, 2006).
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Figure 3.13 Electron microscopy analysis of mouse Cln3 KO fibroblasts
The arrows show late autophagic structures. Panel B is an enlargement of the 
autophagosome highlighted in panel A.
Scale bar=0.5 pm.
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Figure 3.14 Electron Microcopy investigation of CIn3 KO fibroblast
Arrows indicate early autophagosomes.
Scale bar=0.5pm
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3.2.4.1 Autophagosomes but not lysosomes are positive for subunit c 
in the CLN3 KG MEFs
To obtain more information about the abnormal compartments exclusively detected in 
the knock out mouse fibroblasts and to investigate further their putative autophagic 
origin, immunolabelling of ultra-thin cryosections from mouse primary fibroblasts was 
performed. Since the unique organelles share features with the endocytic compartment 
especially the late endosomes/lysosomes, and with autophagosomes, the markers 
selected for the analysis were LC3 and LAMPl respectively.
Since the robust LC3 antibody available to us does not work on cryo samples, we used 
a construct encoding an EGFP tagged form of the LC3 protein kindly provided by Dr. 
T.Yoshimori. WT and KO MEFs were transfected and after 24 hours the cells were 
fixed and prepared for immunolabelling. A GFP antibody was used to detect the GFP 
tagged LC3. EM analysis showed that LC3 was relatively randomly distributed in the 
cytoplasm, suggesting a high level of non specific staining. This prevented a 
distinction between the real staining and the background (not shown).
Ultra-thin cyosections were also stained with LAMPl to label late endosomes and 
lysosomes. Multivesicular bodies (Figure 3.15, panel A and B), lysosomes and also 
small vesicles (panel C) were positive for LAMPl. The autophagosomal organelles 
exclusively present in the KO fibroblasts present just few gold particles representing 
LAMPl (Figure 3.15, panel D and Figure 3.16).
In the Juvenile-onset form of Batten disease, the majority of the storage material 
protein content that progressively accumulates during the disease course consists of 
the mitochondrial ATP synthase subunit c protein .
In order to determine whether primary mouse fibroblasts from the ClnS KO mice 
display storage of subunit c, and to investigate how the storage is distributed in 
relation to the aberrant organelles in mutant MEFs, ultra-thin cryosections were 
stained with an anti subunit c antibody, kindly provided by Professor E.Kominami. 
Subunit c can also be used as a marker of autophagy since turnover of mitochondria is 
controlled by the autophagic pathway.
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Figure 3.15 Ultrathin cryosections of CLN3 KO primary fibroblasts immunogold 
labelled for LAMPl
Arrows indicates autophagosome. Multivesicular bodies (MVB) and lysosomes (L) 
also indicated. * indicates small LAMP-1 positive vesicles.
Protein A gold for Lampl, lOnm.
Scale bar=500nm.
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Figure 3.16Ultra-thin cryosections of Mouse CLN3 KO fibroblasts immunogold 
labelled for Lampl.
Arrows indicate autophagosomes, L indicate lysosomes. Protein A gold for Lampl, 
lOnm. Scale bar=500nM
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Mitochondria are subject to regular turnover and they are directly removed via the 
autophagic pathway (Klionsky and Emr, 2000). In ClnS KO primary fibroblasts the 
subunit c protein was, as expected, present in the internal cristae of mitochondria 
(Figure 3.17, panel A and B). However, subunit c was also seen within the unique 
autophagic compartment of the mutant fibroblasts (panel C and D) and it was not 
present anywhere else. In contrast to Lampl, subunit c heavily decorated the internal 
membrane of the unique compartment suggesting internalization of mitochondria 
within these structures.
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Figure 3.17 Subunit c immunolabelling of ultrathin cryosections of CLN3 KO 
mouse Fibroblasts
Arrows indicate autophagic organelles. LE/L indicate late endosomes/lysosomes 
m indicate mitochondria 
Scale bar=200nM
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3.2.5 Ultrastructural examination of Cln3 KO mouse primary 
neurons
JNCL is a neurodegenerative disease and the hallmark of the disease is the 
accumulation of the mitochondrial ATPse synthase in all the cells of the body. 
However the only cells that are clinically affected and die in the disease are in the 
CNS and the neural retina. For this reason, a morphological examination of primary 
neurons from the available ClnS KO brain was performed. Neurons from the KG 
mouse model and wild type controls were cultured for 10 days and subsequently fixed 
and processed for electron microscopy examination. Neuronal culture has been 
performed by Hannah Mitchison.
At the ultrastructural level, the same aberrant electron dense organelles seen in the 
mutant fibroblasts were observed; these were morphologically classified as late 
autophagosomes (Figure 3.18, panel D and E, white arrowheads). These were present 
just in the KO neurons.
Close to the TON area, many newly formed autophagosomes were also present. They 
were distinguishable from the mature autophagosomes because of their inner content 
which is cytosolic and not electron dense (panel A , B and C indicated as A Vi). 
Furthermore, in the neurons from the KO model, a mitochondrial defect was also 
revealed that was not observed in KO MEFs. Normal and healthy mitochondria were 
present alongside mitochondria deformed, being of significantly bigger size (Figure 
3.18, panel C). This phenotype was later confirmed by another work (Luiro et al., 
2006).
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Figure 3.18 Ultrastractural examination of CLN3 KO neurons
Avi indicate early autophagosomes, white arrowheads indicate late autophagosomes 
(AVI) and m label mitochondria. Scale bar=lpm
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3.3 Discussion
The aim of this part of the thesis was to analyze CLN3 localization at the 
ultrastructural level and basic phenotypes arising from CLN3 loss of function in the 
cells.
3.3.1 CLN3 localization at the ultrastructural level
To study its localization by electron microscopy, HeLa cells were transfected with 
CLN3-GFP and processed for cryo sectioning. CLN3 was found in late endosomes 
and lysosomes as expected but also in small vesicles (lOOnm) some in close proximity 
to the Golgi, some close to the plasma membrane suggesting that CLN3 traffics a lot 
in the cells between organelles(Persaud-Sawin et al., 2004).
Double labelling of CLN3-GFP HeLa cells would have been desirable in order to 
better classify the CLN3 compartment however because of the difficulty of locating 
CLN3-positive overexpressed cells by cryo we did not attempt this experiment.
3.3.2 Impairment in the endocytic pathway
A detailed survey with endocytic markers was carried out in controls and cells 
deficient for CLN3. In both human skin fibroblasts and mouse embryonic fibroblasts 
at the light level the only difference detected with endosomal markers was obtained 
with the early endosomal/recycling endosomal marker R abll and the receptor CI- 
MPR whereas the endosomal markers Lampl, CD63, EEAl were unchanged.
The CI-MPR is a fundamental receptor, which delivers hydrolases from the Golgi to 
the lysosomes where they get employed for degradation of lysosomal material and it is 
critical for lysosomal biogenesis (Pohlmann et al., 1995). In mouse KO cells the CI- 
MPR which normally localizes in both Golgi and endosomes scattered throughout the 
cytoplasm was prevalently detected in the Golgi area.
R abll traffics through the early and recycling compartment and it is thought to 
regulate endosomal/plasma membrane interactions, by controlling membrane traffic,
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through recycling early endosomes. In both human and mouse CLN3 deficient cells 
Rabl 1 is almost completely distributed in the perinuclear/Golgi area. This suggests a 
defect in the endocytic pathway at the level of the Golgi or recycling early endosomes 
in CLN3 deficient cells from JNCL patient and the mouse model.
3.3.3 Impairment in autophagy
In human skin fibroblasts and CLN3 KO fibroblasts and neurons, an increased 
number of autophagosomes was discovered. This was confirmed in both light 
microscopy study and electron microscopy. An increased abnormal number of 
autophagosomes were present in CLN3 deficient cells.
Upregulation of the autophagic pathway due to CLN3 deficiency was also reported, 
after this study was already carried out, in immortalized cerebella cells from the mouse 
model Cln3 confirming that autophagy is misregulated when CLN3 is impaired 
(Cao et al., 2006).
Autophagy is a routine housekeeping process exerted by cells but it is generally 
difficult to see autophagosomes frequently in normal cultured conditions. As a result 
of CLN3 dysfunctions autophagy could be either upregulated in these cells or the 
maturation of autophagosomes could be arrested, blocking their removal and leading 
to accumulation. The major component of the storage material in JNCL is subunit c of 
the mitochondrial ATP synthase. Surprisingly, primary cells in culture were found to 
be able to accumulate the protein, implying that the storage material accumulates very 
quickly.
The presence of a mitochondrial protein within the endocytic compartment may be 
explained by the process of mitophagy, where mitochondria, subject to a very high 
turnover in the cells, get incorporated in autophagosomes for their ultimate removal. 
The only available route in cells for a mitochondrial protein such as the subunit c 
protein to encounter the endocytic pathway is through fusion between endosomes/ 
lysosomes and autophagosomes which have previously incorporated mitochondria. 
These results suggest that when correct functioning of CLN3 is lost by the cells, 
autophagosomes accumulate that are positive for subunit c, mostly in the perinuclear
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area of the cells. Accumulation of autophagosomes could be due to upregulation of the 
autophagic pathway resulting in an increased amount of these structures because the 
cells are not able to clear them, or simply because the cells are failing to deliver the 
necessary hydrolases through fusion of autophagosome with the organelle devoted to 
degradation; the lysosome.
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4 The autophagic pathway in reiation to loss of the 
CLN3 protein
The CLN3 protein is a very hydrophobic, transmembrane protein of unknown 
function. Chapter 3 shows that CLN3 dysfunction creates endocytic and autophagic 
defects, implicating it in both these intimately associated pathways.
Accumulation of autophagic vacuoles has been noted in neurodegenerative diseases, 
including Alzheimer disease and Parkinson’s disease, but their significance is not 
understood (Nixon, 2006; Rubinsztein et al., 2005).
The autophagic pathway provides a double-edged sword in that it can be a promoter of 
cell survival, used when the cells need to remove damaged organelles or require 
protection during a situation of starvation, but it can also promote cell death, perhaps 
when it is excessive. Whether autophagy protects from disease or causes disease is 
unclear (Shintani and Klionsky, 2004).
In all these diseases where an abnormal amount of autophagic structures have been 
reported, it is unclear whether this phenomenon is the result of increased autophagic 
activity or decreased autophagosome maturation for example due to problems with 
autophagosome/lysosome fusion(Settembre et al., 2008).
The autophagic pathway can be dissected into at least 4 key steps: induction of 
autophagy, formation of autophagosomal membrane and maturation of the new born 
organelle, docking and fusion with the lysosome and vesicle breakdown (Reggiori and 
Klionsky, 2002). Although autophagy remains poorly understood, this part of the 
study focussed on an attempt to locate which step of the pathway is affected when 
CLN3 function is defective. In particular, the microtubule- associated protein light 
chain 3 (LC3), the only marker available to label maturing autophagosomes in 
mammalian cells and the use of the electron microscopy were the tools extensively 
employed in this part of the analysis.
89
Chapter 4 Autophagy in relation to loss o f CLN3
4.1 CLN3 and fusion of autophagosomes with lysosomes
While autophagosomes are forming they acquire the microtubule-associated protein 
light chain 3 (LC3) and during maturation they lose LC3 while acquiring the 
endosomal marker Lampl via fusion with the late endosomes and lysosomes. To 
assess if this fusion step is impaired in CLN3 deficient cells, the subcellular 
localization of Lampl was analyzed in conjunction with the autophagosomal marker 
LC3,
4.1.1 Autophagosome-lysosome fusion in JNCL 1 kb patient skin 
fibroblasts
Human skin fibroblasts from controls and JNCL Ikb deletion patients were cultured 
for not more than 20 passages and labelled for indirect immunofluorescence with the 
lysosomal marker Lampl and the autophagosomal marker LC3.
Since in wild type human skin fibroblasts the autophagosome number is low due to a 
low level basal rate of autophagy in this cell type, the autophagic pathway was 
stimulated by amino acid deprivation using BBSS media for 2 hours at 37 °C to induce 
the formation of new autophagosomes.
The starved and non-starved cells were fixed and stained using LC3 and Lampl for 
the indirect immunofluorescence studies as shown in Figure 4.1.
As observed in chapter 3, only a few LC3 positive vesicles representing 
autophagosomes were present in the non-starved wild type cells, in contrast with the 
Ikb deficient non-starved JNCL cells where a conspicuous number of autophagosomes 
were evident in the cytoplasm of the cells (Figure 4.1, upper panel). In the control 
cells, maybe partly due to the low number of autophagosomes it was not possible to 
detect any colocalization between LC3 and Lampl.
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Figure 4.1 Immunofluorescence with LC3 and LAMPl in human skin fibroblasts
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The top panel shows untreated wild type human skin fibroblasts (A) and Ikb deletion 
fibroblasts (B).
The bottom panel shows cells after 2 hours incubation with EBSS media, wild type 
skin fibroblasts (A) and Ikb deletion fibroblasts (B).
Scale bar=10pim
Some of the cells were also grown for 2 hours in EBSS media to induce the formation 
of autophagosomes. In this case, the number of LC3 autophagosomes increases in the 
wild type cells but it was noted that the autophagosome number was markedly 
increased by starvation in the control cells, but starvation did not make such a 
difference to LC3-positive structures in the mutant cells. This was not quantified but 
suggests a state of starvation pre-existing in the mutant cells that is not so greatly 
shifted by amino acid deprivation, while the usual reaction to starvation occurred in 
control cells (Figure 4.1, lower panel). Colocalization between LAMPl and LC3 was 
again, rarely seen.
4.1.2 Autophagosome-lysosome fusion: use of EGFP-LC3
Despite this, since LC3 is the only available marker to identify autophagosomes in 
cells we further attempted to use it. However unfortunately, the antibody from Dr. 
Yoshimori recognizing the endogenous form of the protein is not commercially 
available. It was limited in supply therefore we could not continue using it. Further 
studies were conducted using the overexpressed form of LC3.
Human skin fibroblasts were transfected with EGFP-LC3 using an Amaxa 
nucleofector device and analysed 24h later by indirect immunofluorescence. To 
analyze the autophagy pathway some of the cells were treated with EBSS media for 2h 
to induce the formation of new autophagosomes before fixation. After fixation the 
cells were stained with the lysosomal marker Lampl to analyze the association 
between autophagosomes and lysosomes.
Surprisingly the overexpression of LC3 in either mutant or control human skin 
fibroblasts considerably increased the number of the autophagosomes present (Figure 
4.2) and therefore it was not possible to distinguish the same phenotype difference that
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had been visible using endogenous LC3 (Figure 3.5, Chapter 3). With endogenous 
staining of LC3, a clear difference of the staining between wild type and mutant cells 
was seen; in the wild type cells the protein was visible almost entirely in the cytoplasm 
whereas in the mutant cells it was associated in organelles (Figure 3.5, Chapter 3). In 
these overexpressed cells no difference is apparent. Therefore the attempt to look 
direcly at autophagosome-lysosome fusion in this way was abandoned.
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Figure 4.2 EGFP-LC3 overexpression in human skin fibroblasts induced 
Autophagy.
EGFP-LC3 transfected wild type and Ikb deletion fibroblasts with starvation- 
untreated or 2 hours starved with EBSS were stained with Lampl.
Scale bar=10pm
4.1.2.1 Overexpression of EGFP-LC3 in Cln3 mouse knock out 
primary embryonic fibroblasts
Due to the problem above, we next tried a third approach. Mouse embryonic 
fibroblasts (MEFs) were grown for not more than 4 passages and transfected with 
EGFP-LC3 using an Amaxa nucleofector device. 24 hours later cells were fixed and 
stained for immunofluorescence study.
As for the human skin fibroblasts, LC3-EGFP transfection in embryonic fibroblasts 
from either control or mutant mice notably increased the number of autophagosomes, 
preventing a clear distinction of the CLN3-associated expanded autophagic 
compartment phenotype that had been seen using the LC3 antibody for endogenous 
detection of the protein (Figure 4.3). The aim of this experiment was again the same, 
to analyse colocalization between LC3 and Lampl in order to investigate a putative 
autophagosome-lysosome fusion phenotype. In both wild type and knock out MEFs it 
was rare to see colocalization between the two markers but sometimes possible. More 
commonly, in the KO MEFs the two markers were in proximity without fully 
colocalizing (Figure 4.3, panel B and enlargement from the white square) suggesting 
that autophagosomes and lysosomes were getting close but prevented from fusing. 
MEFs were also starved for 2 hours with EBSS media to induce the formation of new 
autophagosomes (Figure 4.4). The induction of the formation of new organelles 
increased the number of the autophagosomes in the wild type cells whilst in the KO 
MEFs autophagosome number looked less altered but the size of the autophagosomes 
was markedly enlarged. In wild type and knock out the increase in autophagosomes 
was marked as a decrease in general cytoplasmic staining of LC3, and increase in 
vesicular perinuclear staining, which is the expected result of starvation. Any
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difference in the level of colocalization between Lampl and LC3 was difficult to 
assess since this was rarely seen in either wild type or KO MEFs.
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Figure 4.3 EGFP-LC3 transfected wild type and CLN3 KO MEFs labelled with 
LAMPl
Instert shows a magnification image from panel B. Scale bar=10pM
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Figure 4.4 EGFP-LC3 transfected wild type and CLN3 KO MEFs starved for 2 
hours with EBSS media to induce auophagy and labelled with LAMPl
EGFP-LC3 transfected mouse embryonic fibroblasts were starved for 2 hours in EBSS 
media to induce autophagy.
Scale bar=10pM
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4.1.3 Autophagosomes in CLN3 KO MEFs have a fusion defect 
between autophagosomes and lysosomes.
The accumulation of subunit c positive structures in the CLN3 KO MEFs (Figure 
3.17) under nonstarved conditions coupled with the increased size of the 
autophagosomes in starved CLN3-deficient cells compared to non starved suggested 
that the autophagic structures accumulate as a result of an autophagosome/lysosomal 
fusion impairment that leads to a failure in their clearance. We tried to look at this 
problem by the analysis of colocalization between the autophagosomal marker LC3 
and Lampl. However, this did not allow us to an answer to this question due to high 
levels of LC3 positive structures after its overexpression and the subsequent 
difficulties in resolving individual organelles plus the lack of an antibody which 
detects the endogenous protein.
A new approach was therefore adopted to assess if the interaction between the 
autophagic pathway and the endocytic is impaired when CLN3 is deficient. Since 
autophagosomes and lysosomes are connected through fusion events, WT and KO 
MEFs were incubated for one hour in the presence of 4mg/ml of the fluid phase tracer 
HRP, dissolved in the cell growth media. This incubation time was selected to ensure 
labelling of the whole endocytic pathway. Normally, HRP enters the cell via fluid 
phase endocytosis reaching endocytic structures, filling the internal lumen of 
endosomes, late endosomes and lysosomes. The early endosomes are normally 
reached by HRP after a few minutes, and the late endosomes begin to receive HRP 
between 10 to 15 minutes after the cells are exposed to the tracer. After 30 minutes the 
HRP reaches the lysosomes (Tooze and Hollinshead, 1992).
The cells were then fixed and incubated with diaminobenzidine and hydrogen 
peroxide to reveal the location of the HRP, postfixed and processed for electron 
microscopy. By electron microscopy HRP has a characteristic and distinct floccular 
aspect (Figure 4.5).
In the WT MEFs, after fluid phase endocytosis and HRP uptake had occurred, the 
tracer was found to fill the early endosomes, late endosomes and lysosomes as 
expected (Figure 4.5). In the CLN3 MEFs the HRP also reached these organelles but it
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did not reach any of the aberrant autophagic organelles present in the mutant 
fibroblasts (Figure 4.6).
Therefore, the CLN3 KO cells were able to uptake the HRP by fluid phase endocyosis, 
but the HRP did not access those organelles that were previously identified as positive 
for subunit c. This suggested a delay in delivery to autophagosomes, or absence of 
fusion between autophagosomes and lysosomes. In particular some HRP-negative 
aberrant- autophagic structures in CLN3 KO MEFs were observed to be in very close 
proximity to HRP-positive endosomes, emphasising the hypothesis that fusion 
between the autophagic and endocytic pathways was not occurring efficiently (Figure 
4.6, panel A, C and F).
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Figure 4.5 HRP feeding in wild type MEFs indicates HRP positive endosomes
* indicates positive endosomes for HRP. These are recognisable by their floccular 
aspect.
Scale bar=500 nM
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Figure 4.6 CLN3 KO Fibroblasts fed with HRP
* indicates HRP positive endosomes
Arrows heads indicate HRP negative autophagosomes, scale bar=500pm
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4.1.4 Autophagy after CLN3 knock down in HeLa cells
Since the levels of over-expression of LC3 in both mice and human fibroblasts was 
highly variable, and the number of autophagosomes was clearly increased in the wild 
type cells after LC3 was transfected, these technical issues made it difficult to 
distinguish a robust difference in the autophagy phenotype between the control cells 
versus the mutant cells at the light level
An alternative approach towards the use of mutant fibroblasts was attempted by the 
use of gene-silencing oligos against CLN3 in HeLa cells. HeLa cells were transfected 
with two rounds of small interfering RNAs (siRNA) against human CLN3 (materials 
and methods. Chapter 2). HeLa cells were also transfected with scrambled siRNA as a 
control. 24 hours after the second round of siRNA transfection cells were fixed and 
prepared for immunofluorescense studies. Quantification of the CLN3 knock down 
was obtained for all the experiments shown in this and other sections using real time 
PCR. In all siRNA experiments >90% knock down of CLN3 mRNA was confirmed. 
Analysis of the cells by confocol microscopy showed that overexpression of LC3 in 
this system again induced a large increase of the autophagic compartment in cells. 
However the level of autophagy was high in HeLa control cells and also the number of 
the punctae representing LC3 was variable from cell to cell. Since the expression level 
of LC3 was not uniform between cells this made it too complicated to compare the 
mock and CLN3 siRNA autophagic structures.
The expression level of LC3 in HeLa cells was observed at different time points after 
transfection but the level of expression was always very variable from cell to cell. In 
an attempt to standardize the expression level of LC3 in order to compare mock and 
CLN3 siRNA cells, a HeLa cell line stably expressing the LC3 protein tagged with 
EGFP was obtained from the Tolkovsky lab (University of Cambridge) (Bampton et 
a l ,  2005). The stable HeLa LC3-overexpressing cells were transfected with the CLN3 
siRNA or scrambled siRNA and analysed, by immunofluorescence study. 
Unfortunately the basal level of LC3 in these cells was again very high, and in 
addition the levels of LC3 was very variable in different cells in the same culture.
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Therefore, for similar reasons as the transient transfected cells system, the LC3 
expressing stably cells were not a good model to study the maturation of the 
autophagy pathway and their use was abandoned.
Another HeLa cell line was obtained from the Tolkovsky group expressing both LC3- 
EGFP and dsRed-mito, a plasmid which labels mitochondria (Bampton et al., 2005). 
Damaged or old mitochondria are removed by autophagic process of mitophagy such 
that mitochondrial fragments can be detected in the degradative compartment. In this 
LC3-EGFP dsRed-mito cell line, dsRed-Mito has been shown in part to colocalize 
with LC3-EGFP after induction of autophagy (Bampton et al., 2005). We used this to 
investigate whether the removal of mitochondria by autophagy occurs in these cells 
after CLN3 knock down. LC3 and dsRed-Mito double stably expressing HeLa cells 
were transfected with CLN3 siRNA or control siRNA and fixed, 24 hours after the 
second round of transfection, the processed for indirect immunofluorescence. Some 
cells were treated for 2 hours with EBSS to induce newly formed autophagosomes by 
starvation (Figure 4.7). In normal growth conditions the LC3 level was variable from 
cell to cell as expected from the above reported work; however more LC3 positive 
punctae were generally seen after CLN3 knock dovm (bottom left Figure 4.7 left 
panels). Rare colocalization of ds-Red Mito and LC3 was ascertained in both mock 
and CLN3 depleted cells. Upon induction of starvation, overlap was more often 
detected between the mitochondrial marker and LC3 in both mock and CLN3 siRNA 
depleted cells. No gross difference in this change to staining was detected between 
control and siRNA treated cells. This therefore suggests that CLN3 knock down cells 
were able to react after starvation to form new autophagosomes enclosing 
mitochondria. Since there was no obvious difference between wild type and CLN3 
knock down cells, we did not pursue this system further, despite not being able to 
determine whether this is a real co-localization or just an overlap was present.
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Figure 4.7 LC3-EGFP and ds-Red Mito double stably HeLa expressing cells 
transfected with scrambled siRNA and CLN3 siRNA
CLN3 siRNA and scrambled siRNA transfected were observed after no treatment or 
after 2 hours of starvation induced autophagy by culture in EBSS media. Insert shows 
a blow up of the indicated areas in the top panel.
Scale bar=10pm
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4,2 Role o f CLN3 in fusion of autophagosomes with 
components of the endocytic pathway
SNARE proteins are integral parts of the machinery required for recognition and 
fusion between membranes (Chen and Scheller, 2001). SNAREs form complexes 
bridging the gaps between membranes to facilitate fusion. The fusion between 
lysosomes and autophagosomes had been highlighted as of interest for CLN3 
dysfunction so a study was made to discover if SNARE proteins present in the 
endocytic compartment could be identified as part of the autophagic pathway and used 
as tools to dissect the putative defective endocytic-autophagic fusion events in CLN3 
deficient cells.
4.2.1 The Syntaxin 8 SNARE is present In maturing 
autophagosomes
Andrew Peden, (University of Cambridge) provided SNARE antibodies including 
VAMP7, VAMPS, Syntaxin 7, SyntaxinS and V Tlb (Luzio et al., 2007). These were 
chosen for their reported localization and role in the endocytic compartment.
HeLa cells stably expressing EGFP-LC3 (Bampton et al., 2005) were prepared for 
indirect immunofluorescence and labelled with individual SNARE antibodies. A 
positive association of LC3 and a SNARE antibody in this initial study was only 
detected with the Syntaxin 8 marker (not shown).
Syntaxin 8 is present in late endosomes and lysosomes and it mediates both homotypic 
late endosome fusion and late endosome/lysosome heterotypic fusion (Pryor et al., 
2004). It forms a complex with V tlb, syntaxin 7 and endobrevin (Antonin et al., 
2000).
Since Syntaxin 8 is localized in the late endosomes and lysosomes and sometimes 
colocalizes with the lysosomal protein Lampl, triple staining of Lampl, LC3 and 
Syntaxin 8 was performed to analyze if the association with LC3 and Syntaxin 8 takes 
place after the autophagosomes are fused with the lysosomes.
HeLa cells stably expressing LC3 were fixed and labelled with Lampl and Syntaxin 8 
(Figure 4.8).
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SYNTAXIN 8 EGFP-LC 3 LAMPl
Figure 4.8 The SNARE protein Syntaxin 8 is associated with maturing 
autophagosomes.
LC3 stable expressing HeLa cells were fixed and labelled with the late 
endosomal/lysosomal marker Lampl and the SNARE antibody Syntaxin 8. The white 
box and arrow highlight a LC3 and Syntaxin 8 puncta co-staining representing a 
maturing autophagosome which it is not postive for Lampl.
Scale bar=10pm
The immunofluorescence analysis showed that the SNARE protein Syntaxin 8 is 
present in the late endosomes, lysosomes as has been described previously (Pryor et 
ah, 2004). In addition, Syntaxin 8 was sometimes observed in autophagic structures by 
colocalization with LC3 and sometimes no Lampl was observed in the same puncta 
(Figure 4.8, box).
V tlb is specifically required for the stability of the Syntaxin 8 protein (Atlashkin et al., 
2003). In V tilb knock out mice, Syntaxin 8 is degraded and the mice present with an 
accumulation of autophagic structures in hepatocytes. This suggests a possible role for 
Syntaxin 8 in the autophagic pathway. Since Syntaxin 8 was associated with 
autophagosomes, we hypothesised that Syntaxin 8 could possibly have a role in fusion
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between late endosomes/lysosomes and autophagosomes and could therefore be 
affected when CLN3 is deficient in cells.
To address this question cells stably expressing LC3 were treated with the CLN3 
siRNA and prepared for immunofluorescence. Cells were fixed and labelled with 
Syntaxin 8 and Lampl or first treated with 2 hours incubation in EBSS to induce 
starvation and the formation of more autophagosomes before fixation and analysis.
In both mock and siRNA treated cells the distribution of Syntaxin 8 was identical, 
suggesting that there is no Syntaxin 8 related phenotype arising from loss of CLN3 
function (Figure 4.9).
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Figure 4.9 The Syntaxin 8 protein is not affected by CLN3 siRNA
EGFP-LC3 stably expressing HeLa cells were transfected with control and CLN3 
siRNA. Some cells were treated for 2 hours with EBSS media to induce the formation 
of new autophagosomes. The boxes highlight autophagosomes puncta.
Scale bar=10pM
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4.3 Phagocytosis and CLN3
In CLN3 deficient cells, the number of autophagosomes is increased and here we have 
shown that autophagosomal maturation may be arrested or delayed due to impaired 
fusion of lysosomes with autophagosomes.
In light of the multiple technical difficulties we encountered with a detailed analysis of 
autophagy a different approach was made to examine a cellular pathway related to but 
potentially more easily studied than autophagy.
For an alternative assessement of wether a ly so so me fusion is defective when CLN3 is 
deficient, an analysis of the effect on phagoctytosis of CLN3 deficiency was 
performed.
Phagosomes, like autophagosomes, undergo a process of maturation which includes 
similarly contacts with the endo-lysosomal system and culminates in fusion with 
lysosomes (Tjelle et al., 2000) (Vieira et al., 2002). Importantly, fusion with 
lysosomes is an essential step for both phagosomes and autophagosomes which 
thereby receive the hydrolases necessary for the degradation of their content.
4.3.1 CLN3 KO MEFs are able to phagocytose latex beads
Professional phagocytic cells, such as macrophages, recognize pathogens via specific 
receptors and then employ the phagocytic pathway in order to digest and eliminate 
them from the cell.
The phagocytic pathway can be divided into several steps culminating with the fusion 
with lysosomes (Tjelle et al., 2000).
As an alternative to the use of primaiy mouse macrophages, fibroblasts cell lines can 
be used to analyse phagocytosis. These are transfected with phagocytic receptors to 
obtain ‘engineered phagocytes’ (Huynh et al., 2007) with the capacity to recognize and 
internalize an opsonised host. CLN3 KO and WT MEFs were transfected with the 
FcIIX receptor (referred to here as FcR) (Caron and Hall, 1998) and after 24 hours 
were fed with 3 pM latex beads, added directly in the medium of the cells, previously 
opsonized with human IgG. The beads were allowed to internalize for 30 minutes at
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37 C° after a brief centrifugation of the cells with the beads to first allow the beads to 
attach at the PM and synchronize phagocytosis. Cell were then stained with anti 
human IgG 480 secondary antibody, then fixed and stained with anti human IgG 
secondary antibody to detect the presence of the beads.
Importantly, FcR-transfected CLN3 KO MEFs were able to internalize opsonized 
beads (Figure 4.10).
Figure 4.10 CLN3 KG MEFs are able to internalize opsonized latex beads
Cells were transfected with FcR and 24 hours later were fed with latex beads for 1 
hour. Cells were fed with latex beads for 1 hour and stained with secondary antibody 
anti 480 IgG to label external beads, then fixed and stained with anti 680 IgG 
secondary antibody to label all the beads.
The white square includes two cells which have been internalized the beads.
Nuclei were stained with DAPI. White arrows indicate external beads.
Axioscop picture, magnification 20X.
4.3.2 In CLN3 deficient fibroblasts the fusion between 
phagosomes and endosomes is impaired
To measure and compare phago some-ly so some fusion in transfected FcR expressing 
MEFs, both WT and CLN3 KO cells were transfected with the FcR construct using an 
Amaxa nucleofactor device. After 24 hours cells were exposed to previously human 
IgG-opsonized 3 |i,m latex beads. To synchronize phagocytosis, cells with the beads 
were briefly spun down.
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The phagosomes were allowed one hour at 37 °C to mature and cells were brought to 4 
°C and incubated with anti human IgG secondary antibody to label all the external 
beads. Subsequently, cells were fixed and stained with Lampl to assess if the 
phagosomes were able to fuse with lysosomes. Both WT and CLN3 KO cells were 
analysed by confocal microscopy and > 1 0 0  internal beads were counted.
In both WT and CLN3 KG MEFs, many beads were internalized but in CLN3 
deficient cells fewer internal beads were positive for Lampl (Figure 4.11). The 
internalized beads were divided into Lampl positive and Lampl negative ( Table 4.1).
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Table 4-1 Quantitation of phagosomes which undergo fusion with lysosomes as 
seen by Lampl labelling
Quantitation of the fraction of phagosomes positive for the endocytic marker Lampl. 
WT and KG MEFs transfected with FcR after 24 hours were fed for 1 hour with latex 
beads and then prepared for immunofluorescence studies. Data are means ± SD of 
three experiments with s i 00 internalized phagosomes from s  20 cells. Error bars 
represent standard errors; p=0 .0 0 2 .
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Figure 4.11 LAMPl immunostaining and phagocytosis by FcR transfected MEFs
WT and KO MEFs were fed with latex beads 24 hours after transfection with FcR. 
Phagosome maturation was allowed to proceed for 60 minutes. Cells were then 
prepared for indirect immunofluorescence studies. External beads were stained with 
anti IgG 680 secondary antibody (far red), all beads were stained with anti 488 IgG 
secondary antibody (green).
Cells were also stained with Lampl (594 anti rat secondary antibody used- red).
Scale bar=10p,m
The proposed failure in proper lysosome fusion and recruitment of LAMPl to 
phagosome membranes was then investigated at the ultrastructural level; FcR 
transfected WT and CLN3 KO MEFs were allowed to internalize opsonized latex 
beads for 1 hour at 37 °C and then immediately fixed and embedded for electron 
microscopy study.
The analysis by EM shows a very striking difference between the beads internalized 
from the WT cells versus the CLN3 KG cells (Figure 4.12).
In the WT cells, all the latex beads analysed were surrounded by a smooth membrane 
and occasionally a few vesicles were observed in between the phagosomal membrane 
and the latex bead, suggesting that a fusion event with the endocytic pathway had 
happened. In contrast, in the KG cells, between the phagosomal membrane and the 
latex bead, membraneous structures were accumulated, suggesting that perhaps, a 
fusion event had happened, presumably involving early endosomes and multivesicular 
endosomes, but that phagosomal maturation was arrested at this stage.
To further analyse fusion events of phagosome with the endocytic pathway, HRP was 
fed into cells to label late endosomes/lysosomes and to confirm the presence of an 
impairment in fusion between the endocytic pathway and the phagosomes.
4mg/ml of HRP was added to the media of MEFs previously transfected with FcR. 
Cells were incubated in HRP for 90 minutes, after which cells were washed several 
times and the HRP media was substituted with fresh media for 5 hours to allow the 
tracer to arrive to the lysosomes and to clean from early endocytic structures. 
Subsequently, opsonized latex beads were exposed to the cells and after 1 hour the 
MEFs were fixed and processed for EM analysis. The distribution of HRP along the
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surface of the bead indicates fusion. The retention of HRP within vesicles trapped 
against the surface of beads shows a strikingly different phenotype.
The beads (^100) were counted (
Table 4-2).
Figure 4.12 EM characterization of phagosomes from FcR transfected MEFs
Fc receptor transfected WT and CLN3 KO MEFs were fed for 1 hour with latex beads 
after 24 hours after transfection and then processed for electron microscopy study.
In wild type MEFs a representative image show that a fusion event of phagosome with 
early and perhaps late endosomes happened as suggested by vesicles visualized in 
between the phagosomal membrane and the bead (arrow). In the KG MEFs complex 
membraneous structures were instead observed in between the phagosome and the 
bead (arrow)
Scale bar=lpm
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Table 4-2 Quantitation of HRP positive latex beads in FcR transfected MEFs
Quantitation of the fraction of phagosomes postive for the endocytic tracer HRP. 
Data are means of s i  00 phagosomes.
\
Figure 4.13 Wild type and CLN3 KO MEFs transfected with Fc receptor, fed 
with HRP and latex beads
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Fc receptor transfected MEFs were fed with HRP for 90 minutes, chased for 5 hours 
and fed with latex beads for Ih. HRP is present in between the phagocytic membrane 
and the bead in the wild type cells (arrow). In the KO cells, in between the phagocytic 
membrane and the bead no HRP was present (arrow).
Scale bar=l pM
4.3.3 Fusion between phagosomes and early endosomes is also 
compromised in CLN3 KO MEFs
The measurement of phago some-ly sosome fusion in Fc receptor transfected MEFs 
showed a defect in fusion in the CLN3 KG cells. Before fusing with lysosomes, 
phagocytic vacuoles interact with both early and late endosomes. To determine at 
which stage the maturation is arrested, the early endosomal marker EEAl was used to 
assess if an earlier stage of fusion between autophagosomes and endocytic pathway is 
also impaired.
WT and KO MEFs were transfected with FcR and 24 hours later latex beads were 
added to the cells, then beads and cells were briefly spun down to syncronize 
phagocytosis and subsequently the cells were allowed to internalize the beads for 15 
minutes at 37C°. The shorter incubation time meant the majority of beads are at the 
endosome fusion stage, rather then late endosome, and therefore still retain the early 
marker EEAl on the membrane. As previously done for Lampl, cells were fixed and 
stained for immunofluorescence studies.
Internalized latex beads were counted (<I00).
In the wild type MEFs more internalized beads were positive for EEAl in contrast 
with the ones internalized by the CLN3 KO MEFs (Table 4-3).
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Table 4-3 Quantitation of phagosomes undergoing fusion with early endosomes
Quantitation of a fraction of phagosomes positive for the endocytic marker EEAl. 
Data represent a 100 internalized beads from s  20 cells.
4.4 Discussion
At the beginning of our preliminary survey an increased number of autophagosomes 
were observed in cells deficient for CLN3 as summarised in chapter 3.
Lysosomal storage diseases are caused by over 40 different genes and clinically they 
affect different organs but most often they cause severe damage to the nervous system 
(Neufeld, 1991). In the past three years the involvement of autophagy in lysosomal 
storage disorders and neurodegenerative disorders has became clearer. For example, 
accumulation of autophagosomes (AVs) has been reported in Batten disease caused by 
deficiency in cathepsin D (Koike et al., 2005) and Mucopolysaccharidosis (Settembre 
et al., 2007). We found in CLN3 deficient fibroblasts and neurons that 
autophagosomes accumulate. During the course of this work another group published 
related findings for CLN3 (Cao et al., 2006). We attempted to verify if the 
accumulation of autophagosomes was due to reduced clearance after their formation 
and maturation due to an absence of fusion between lysosomes and autophagosomes. 
In different neurodegerative conditions, such as Alzheimer disease (Nixon et al., 2005)
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and Huntington disease (Rubinsztein et a l, 2005), the hypothesis of defective fusion 
between lysosomes and autophagosomes has been reported but none of these studies 
conducted so far suggested a good approach to establish if this hypothesis is true. At 
the beginning o f our study, to follow the maturation of autophagosomes in CLN3 
deficient cells, a light microscopy approach was taken, using LC3 in conjunction with 
the lysosomal marker Lampl, to visualize if LC3 and LAMPl could meet or not when 
CLN3 is deficient. The level of LC3 in non starved wild type cells is low whereas in 
CLN3 deficient cells the level is higher but no colocalization with Lampl was 
detected supposing possible autophagosome maturation defect. After starvation the 
level of LC3 increased in both wild type and mutant cells, but the localization with 
Lampl was hardly seen, probably due to the fact that LC3 is getting rapidly degraded 
while the autophagosomes are maturing at the same time as Lampl is being acquired 
via endocytic fusion events. In CLN3 deficient cells after starvation, the LC3-positive 
autophagosomes became bigger than those in both unstarved mutant cells and starved 
wild type cells, indicating a defect in their maturation was likely. Starvation conditions 
did not have such as a dramatic effect on mutant versus wild type cells, suggesting the 
CLN3 deficient cells are already effectively started.
To assess the autophagic pathway in a more detailed and quantitative manner, we 
required an LC3 antibody to detect the endogenous protein unfortunately. Not enough 
of this was available to finish this part of the study to detect a fusion defect at the light 
level.
An increase in the number of autophagosomal membranes was demonstrated by both 
light microscopy and electron microscopy but the use of the EGFP-LC3 construct 
employed in this chapter instead of the endogenous antibody complicated the 
phenotype. This is because the overexpression of LC3 in fibroblasts drastically 
increased the basal number of autophagic vacuoles in cells, thereby removing any 
clear cut difference in LC3 levels by introduction of either CLN3 or starvation.
For this reason electron microscopy was employed for the visualization of the 
autophagic structures.
To label the structures at the ultrastructural level and determine if a connection with 
the endocytic pathway was impaired, a fluid phase marker of the endocytic pathway.
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HRP was employed. The fluid phase marker reached the endosomes and lysosomes in 
both wild type and knock out cells but not the expanded autophagic compartment on 
KO cells. This indicates that the endocytic pathway to the lysosomes is unaffected by 
CLN3 dysfunction but there is a clear block in the communication between endocytic 
and autophagic pathways due to CLN3 deficiency.
These are the first reported findings that can confirm morphologically that an increase 
in the number of autophagic structures found in the lysosomal disease JNCL is related 
to a defect in fusion between autophagosomes and lysosomes.
The study by Cao et al., published during this work suggested that distruption at the 
level of autophagosomal maturation was likely, but they showed a reduction of LC3 
positive structures in their CLN3 deficient cerebellar cell line and reduced endocytosis 
in addition to loss overlap on endocytic tracer and lysotracker.
Poor information is available on the machinery involved in fusion of autophagosomes 
with lysosomes and what mechanisms are used by the cells to exert these events. For 
this reason a survey of the SNARES, so far reported to be involved in heterotypic and 
homotypic fusion between endosomes/lysosomes, was carried out. Interestingly a 
SNARE, Syntaxin 8  reported to be important for late endosomes homotypic fusion and 
heterotypic late endosomes/lysosome fusion (Luzio et al., 2007) was found to 
colocalize with LC3 after overexpression of LC3-EGFP. This result could be 
potentially interesting for a more detailed analysis of this SNARE and its involvement 
in the autophagic pathway. No difference with the syntaxin 8  antibody was noticed 
after CLN3 silencing in conjunction with LC3 expression in HeLa cells and for this 
reason no more work on the syntaxin 8  marker was attempted. We encountered 
significant problems using LC3 overexpression to analyse autophagy. This was due 
not only to its effect in increasing the basal level of autophagy in transfected cells such 
that altered autophagy levels were masked, as compared staining of LC3 using the 
endogenous antibody. In addition, the heterogeneity of the level of LC3 expression 
between transfected cells, in transfection experiments prevented reproducible results. 
The study o f defects in autophagy and fusion events with autophagosomes and 
lysosomes related to CLN3 deficiency has been a challenging project since induction.
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regulation and mechanisms with in the autophagic pathway are still not well 
understood.
It would be of interest, not only for CLN3 but also for other lysosomal storage 
diseases and neurodegenerative diseases, to continue this research into the autophagic 
pathway in Batten disease, carrying out studies on the relationship between 
autophagosomes and the endocytic pathway. Electron microscopy remains the best 
technique to visualize and differentiate the autophagosomes from lysosomes before 
they have met, due to the paucity of markers able to classify just the autophagosomes. 
The two pathways, autophagic and endocytic, are physically well connected in cells 
and it is a high priority to discover the molecules involved that they share.
It will be hard to continue analysis of CLN3 and its role in both endocytic and 
autophagic pathways without more basic information about the molecular mechanism 
underlying autophagy.
4.4.1 Delay In recruitment of endocytic markers to phagosomes In 
CLN3 deficient cells
Since so little is known about the autophagic pathway and no easy assay of autophagic 
function is available, we decided to approach function of CLN3 in the endocytic 
pathway via the phagocytic pathway, which presumably share essentially the same 
fusion steps with the lysosome as the autophagic pathway.
Since in autophagy the fusion event between lysosomes and autophagosomes is 
impaired by loss o f CLN3, we hypothesed that phagosome-lysosome fusion events 
could also be malfunctioning in CLN3 deficient cells.
Phagocytosis involves different steps of vesicular maturation which include a kiss and 
run or fusion event with endosomes and conclude with a fusion step with the lysosome 
(Vieira et al., 2002). The latter is a fundamental step to bestow lytic properties to the 
phagosomes. In view of the fact that phagocytic fusion events result in the delivery to 
phagosomes of membrane proteins such as Lampl and EEAl, we tested the possibility 
of an impairment o f the endocytic and phagocytic pathway using those markers. We 
showed that the recruitment of endocytic markers to phagosomes is defective or
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delayed in CLN3 deficient cells. These experiments indicated that loss of CLN3 
function results in a delay in recruitment of endocytic markers to phagosomes. 
However these experiments did not indicate the exact time point of the delay since in 
our protocol, the beads were fed continuously and the analysis carried out without a 
chase. Since a proportion of beads remained stuck at the PM even after repeated 
washes, this prevented the possibility of a meaningful chase.
A similar phenotype has been observed in Lampl/Lamp2 deficient MEFs, where cells 
prepared for the same experiment presented membranous accumulation between 
phagosomal membrane and the phagosomes suggesting a defect in phagosomal 
maturation i.e., the possibility of a fusion event with a MVB but not with lysosomes 
(Huynh et al., 2007).
The autophagic and phagocytic pathways are distinct and separate processes but both 
are defective when CLN3 is deficient. This is suggestived a general impairment in 
fusion events at the lysosomal level resulting from lack of CLN3 function.
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5 Mannose 6 phosphate receptor distribution in CLN3 
deficient cells
The morphological analysis of cells deficient for the CLN3 protein showed an aberrant 
accumulation of material in membrane-bound organelles, likely to be of 
autophagosomal origin, indicating a defect in the degradation of their content. 
Lysosomes and autophagosomes require lysosomal hydrolases to perform their 
degradative function.
The aim of the work presented in this chapter was to determine if impaired recruitment 
of the hydrolases from the Trans Golgi Network (TON) to the lysosomes and 
consequent failure in lysosomal degradation was linked to mislocalization of the CI- 
MPR that had been observed and was the cause of CLN3 related autophagosome 
pathology.
The CI-MPR executes a fundamental role in the recognition and delivery of these 
hydrolases. Result from chapter 3 suggested impaired trafficking of CI-MPR in CLN3 
deficient cells (Figure 1.7). During their transport from the ER to the Golgi, the 
enzymes destined to be delivered to the lysosomes are postransationally modified by 
the addition phosphorylated mannose residues. These are recognized by the mannose 6  
phosphate receptors (MPRs) and are subsequently sorted into clathrin coated vesicles 
and transported to late endosomes, where the enzymes dissociate from the receptors 
and are subsequently delivered to lysosomes for use. The MPRs are then recycled back 
to the TGN for a new cycle.
In this part of the work an analysis of the route taken by the endocy to sed CI-MPR, 
was undertaken in collaboration with Dan Metcalf in the Cutler lab.
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5.1 Effect o f CLN3 deficiency on CI-MPR-receptor trafficking
Following from its altered distribution in CLN3 KO mouse fibroblasts the distribution 
of the CI-MPR receptor was examined more closely in CLN3 siRNA treated HeLa 
ceils to test whether the proposed impairment in the degradation ability of lysosomes 
and autophagosomes was due to a defect in CI-MPR trafficking and the correct sorting 
of hydrolases. A CD8 -CI-MPR reporter construct was used in combination with CLN3 
siRNA to provide a more flexible system to determine the reason for the CI-MPR 
defects.
5.1.1 Steady state distribution of CI-MPR in CLN3 depleted HeLa 
cells
To determine any effect of a loss of CLN3 on CI-MPR distribution, as in chapter 4, 
RNAi was performed on HeLa cells using exon 6  and exon 10 small interfering RNA 
(siRNA) duplex oligonucelotides to silence expression of human CLN3 (material and 
methods, chapter 2). HeLa cells were transfected with the siRNA using an Amaxa 
nucleofector device, and very little detectable mRNA was found by real time PCR 72 
hours after two rounds of siRNA transfection in comparison to HeLa control cells 
treated with a scrambled siRNA. 85-90% knockdown was confirmed for all 
experiments described.
The effect of CLN3 loss on CI-MPR receptor distribution was analysed by indirect 
immunofluorescence and confocol microscopy, staining for endogenous CI-MPR and 
comparing CLN3 siRNA depleted cells versus labelled control cells as shown in 
Figure 5.1. From this first investigation, the CI-MPR staining in the siRNA treated 
cells looked more concentrated in the pericentriolar area and less dispersed in the 
cytoplasm.
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MOCK CLN3 KD
Figure 5.1 Immunofluorescence labelling of CI-MPR in CLN3 knock down HeLa 
cells and mock treated control cells.
Hela cells transfected with CLN3 siRNA or transfected with control were fixed after 
24 hours after the second round of transfection and stained for CI-MPR antibody. 
Scale bar=10p,m
5.1.2 Altered steady state distribution of CD8-CI-MPR chimera in 
CLN3 depleted HeLa cells.
To extend the analysis of CI-MPR localisation, distribution and trafficking, constructs 
expressing a CDS reporter protein in which the cytoplasmic tail of CDS was replaced 
with the cytoplasmic tail of the CI-MPR (Seaman, 2004) were expressed in HeLa cells 
(Figure 5.2). In this way the CI-MPR protein is more readily detected than endogenous 
CI-MPR, using a commercially available anti CDS antibody.
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Figure 5.2 The cytoplasmic tail of CD8 is replaced with the trasmembrane- 
cytoplasmic tail (TM/C) of CI-MPR
(Seaman, 2004)
CLN3-depleted HeLa cells and control cells were transiently transfected with the 
CD8 -CIMPR construct and subsequently fixed and labelled by indirect 
immunofluorescence with antibodies against CDS. The localization was assessed by 
co-staining with the trans-golgi network marker TGN46.
In cells transfected with scrambled siRNA, the CI-MPR was present at the TON as 
seen by the co-localization of CDS and TGN46 (Figure 5.3, panel A). It was also 
distributed in a population of endosomes visualized as scattered dots positive for the 
CDS antibody, present throughout the cytoplasm. In contrast, the CLN3 depleted cells 
had an altered CDS- CI-MPR distribution where the anti CDS was mostly distributed 
at the TGN and was partially missing from the endosomes (Figure 5.3, panel B). The 
accumulation of CI-MPR at the TGN in CLN3 depleted cells and relative absence 
from peripheral endosomes suggested a defect in its cycling route.
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Figure 5.3 Immunofluorescence of mock transfected and CLN3 slRNA treated 
HeLa cells expressing CD8-CI-MPR
(A) Control cells and (B) CLN3 depleted cells labelled with TGN46 and CDS to 
visualize the localization of CI-MPR in the cells. In control cells (A) CDS is present in 
both Golgi and endosomes in contrast CLN3 depleted cells where the majority of the 
CDS is present in the TGN.
Scale bar=10pm
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5.2 CI-MPR is held in the TGN in CLN3 knock down HeLa cells
The altered steady state distribution of CI-MPR in CLN3 depleted cells suggested a 
defect in the trafficking o f the receptor.
This is a well studied and characterized receptor that follows a complicated route 
inside cells that involves multiple sorting steps, trafficking via the plasma membrane, 
endosomes and Golgi. In order to follow the CI-MPR route in CLN3 deficient cells, 
the CI-MPR path was analysed from the plasma membrane to the endosomes and 
Golgi, by feeding the cells with the CD8  antibody.
5.2.1 Endocytosed CDS is almost exclusively detected at the TGN
To determine if the route from the plasma membrane to the Golgi was impaired, HeLa 
cells depleted for CLN3 and expressing the CD8 -CIMPR chimera were fed for 3 hours 
at 37 °C with a CD8  monoclonal antibody. After internalization, cells were fixed and 
stained by indirect immmunofluorescence with the trans-Golgi marker TGN46 to 
assess the arrival of the CDS at the Golgi (Figure 5.4)
As expected, in scrambled siRNA control cells the CDS was present in both TGN and 
endosomes as the result o f the continuous feed and subsequent trafficking of the 
reagent in the cells, as shown in panel A. The distribution is similar to that seen for the 
steady state distribution of the receptor in Figure 5.3, panel A.
In contrast, the distribution of the CI-MPR in the CLN3 knock down cells was 
severely altered with a predominant localization at the TGN, where the CDS 
accumulated with a brighter and tighter stain than in the control cells, to the detriment 
of the endosomal population (panel B),
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Figure 5.4 Immunofluorescence of mock transfected cells and CLN3 siRNA 
treated HeLa cells expressing CD8-CI-MPR and fed with the CDS antibody for 3 
hours
Cells were incubated for 3 hours continuously with the antibody CDS prior to fixation. 
Cells were labelled with TGN46 followed by appropriate secondary antibodies. In 
mock transfected cells there is colocalization of endocytosed CDS with the Golgi 
marker but a good bulk of CDS is present also in endosomes scattered throughout the 
cytoplasm (A) in contrast with CLN3 depleted cells (B) where the majority of the 
endocytosed CDS is present just in the TGN. Scale bar=10pm
12S
Chapter 5 CLN3 and CI-MPR
( I N3-.MVC
■ f :
/ -  • 
• y , , .
Figure 5.4 b CLN3-Myc overepression rescue the CD8-CI-MPR localization in 
CLN3 siRNA treated cells.
CD8 -CI-MPR was localized at the TGN and in the endosomal population in CLN3 
siRNA cells suggesting phenotype rescue and confirming the specificity of the CLN3 
siRNA in missorting the CI-MPR at the TGN area to the detriment of the endosomal 
population. Scale bar=10pm
This finding raised two different questions. Firstly: which part of the trafficking 
itinerary of the CI-MPR was deficient resulting its accumulation at the TGN and 
secondly, whether the CI-MPR was getting degraded by the lysosomes.
Endocytosed CI-MPR enters sorting endosomes and subsequently recycling early 
endosomes. A proportion of the receptor eventually proceeds to the TGN, another 
fraction returns to the PM and finally a proportion of CI-MPR also goes to the 
lysosomes from the early endosomes(Lin et al., 2004). Only a small fraction can 
generally be detected in the endosomal compartment where the receptor dissociates its 
ligand due to acidic endosomal environement due to the acidic endosome environment 
and comes back to the TGN by a process involving the retromer complex (Seaman, 
2005).
5.2.2 CI-MPR retention in the TGN is a specific phenotype due to 
CLN3 loss that can be reversed by restoring CLN3 expression
CLN3 loss caused a re-distribution of CI-MPR which could influence its primary 
function of delivery of hydrolases to the lysosomes and consequently limit lysosomal 
degradation, causing the build-up of storage material in autophagosomes and
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lysosomes in CLN3 deficient cells. The specificity of the siRNA-mediated CLN3 
knock down in HeLa cells was confirmed by re-introducing CLN3 to the cells by the 
overexpression of a Myc tagged CLN3 (Pohl er a l , 2007) construct in conjunction 
with siRNA, during the second round of transfection in experiments. Twenty four 
hours after the second round of transfection with the CLN3 siRNA/mock transfection 
and CLN3-Myc co-transfection the cells were fed with the CDS antibody for 3 hours, 
immediately fixed and labelled with the TGN 46 antibody. CD8 -CI-MPR was 
localized at the TGN and in the endosomal population in both control and CLN3 
siRNA cells suggesting phenotype rescue and confirming the specificity of the CLN3 
siRNA in missorting the CI-MPR at the TGN area to the detriment of the endosomal 
population (Daniel Metcalf, UCL, figure 5.4b).
5.2.3 CI-MPR is not degraded by lysosomes in the CLN3 depleted 
cells
After being transported in coated vesicles from the TGN to late endosomes/lysosomes, 
the hydrolases dissociate at their destination from the CI-MPR allowing the receptor to 
come back to the TGN for a new cycle. In this way the receptor is recycled for re-use 
rather then being degraded and wasted.
In CLN3 depleted cells, the lack of CI-MPR outside of the TGN area raised the 
possibility that the receptor has being degraded by lysosomes instead o f being returned 
for a new cycle. To test this hypothesis HeLa cells depleted for CLN3 and expressing 
the CD8 -CI-MPR chimera were treated with the protease inhibitors leupeptin and 
pepstatin for 3 hours prior to and during the 3 hours of the CD8  antibody feeding to 
the cells at 37 degrees. After the protease treatment and internalization by feeding, 
both CLN3 knock down and control cells were fixed and stained with the TGN46 
antibody to detect the Golgi compartment and Lampl antibody to visualize the late 
endosomes/lysosomes (Figure 5.5).
In control cells, the CI-MPR is detected at the TGN and in endosomal population as 
shown previously (panel A). In the CLN3 depleted cells, no colocalization of the CDS
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antibody with the lysosomal marker Lampl was detected and the majority was in the 
TGN (panel B). This confirmed the relative lack of CI-MPR outside the TGN in 
knockdown cells and excluded the possibility that the CI-MPR was retained and 
degraded in the lysosomes.
3 H O U R S FE E D IN G  + L E I P/PEP
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Figure 5.5 Immunofluorescence of mock and CLN3 siRNA treated HeLa cells 
expressing CD8-CI-MPR and fed with the CDS antibody in the presenee of 
protease inhibitors
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Cells were treated with the protease inhibitors leupeptin and pepstatin for 3 hours prior 
to and during 3 hours of CD8  antibody uptake. Cells were fixed and stained with 
TGN46 and Lam pl. Control cells (A) showed the presence of CDS in both TGN and 
endosomes in contrast with CLN3 depleted (B) cells where the CDS antibody is 
almost exclusively colocalizing with TGN 46. Scale bar=10pm
5.3 CI-MPR is not accumulated at the plasma membrane in 
CLN3 depleted cells
The analyses by indirect immunofluorescence of CI-MPR localization in CLN3 
siRNA depleted cells and corresponding controls showed a pronounced distribution at 
the TGN and an absence from the endosomes in the siRNA cells. It was possible that a 
part of the CI-MPR might be stored or retained at the plasma membrane in CLN3 
depleted cells. To explain this phenotype, an analysis was performed to rule out this 
possibility.
To assess if the CI-MPR was accumulated at the PM, CLN3 depleted and control 
HeLa CD8-C1-MPR stably expressing cells were fed with the CDS antibody for 3 
hours continuously. Cells were extensively washed to remove unbound CDS antibody, 
then successively harvested, pelleted and re suspended in FACS buffer, with 488 Alexa 
secondary antibody. Cells were incubated on ice for 30 minutes with the antibody to 
prevent endocytosis and immediately fixed. Cells were not permeabilized, in order to 
monitor just the CI-MPR pool at the PM.
The FACS analysis revealed a lower level of CI-MPR at the PM in the CLN3 depleted 
cells than in control cells (Figure 5.6).
In the context o f previous results, the flow cytometry data suggested that the biggest 
pool of internalized CI-MPR in the CLN3 siRNA cells is at the TGN and that once it 
enters the cells, it does not cycle back to the PM. Since the internalized CDS did not 
get degraded by the lysosomes nor accumulate at the PM, it is possible that all the fed 
CDS is retained exclusively at the TGN; this raises the possibility that CLN3 exers its 
function in the TGN.
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Figure 5.6CeII surface expression of CD8-CI-MPR in mock and CLN3 siRNA 
CD8-CI-MPR
HeLa cells stably expressing CD8 -CI-MPR were fed for 3 hours with anti CDS. Cells 
were extensively washed and labelled with an Alexa 488nm secondary antibody, cells 
were then fixed in formaldehyde before analysis by FACS. Unstained cells (blue), 
siRNA treated cells (red), mock transfected cells (green).
The graph shows the mean of the percentage of the CDS fluorescence at the plasma 
membrane ± SD for the same experiment repeated three times.
5.4 Morphology of the Golgi apparatus in control cells and in 
CLN3 depleted cells
Since in CLN3 depleted cells expressing the CD8-C1-MPR chimera the MRP is 
present almost exclusively at the TGN, this raised the possibility that a dramatic 
morphological defect could occur in the Golgi after CLN3 siRNA transfection which 
prevents the exit of the CI-MPR from the TGN.
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5.4.1 Analysis of the TGN in control cells with the use of the TGN- 
38-HRP chimera
The Golgi apparatus is composed of stacks of flattened, adherent cisternae which are 
connected together and these reside next to the microtubular organizing centre. From 
the trans Golgi network clathrin coated vesicles bud off to reach their destination.
To study the morphology of the Golgi apparatus after loss of CLN3 by siRNA 
treatment in HeLa cells, a preliminary study on normal control cells was performed to 
define the TGN in these cells by electron microscopy using a TGN-38-HRP chimera. 
HeLa cells were fixed 24 hours after transfection with the TGN-38-HRP chimera. 
Immediately after fixation the cells were treated with diaminobenzidine and hydrogen 
peroxide to reveal the location of the HRP and subsequently processed for embedding 
for electron microscopy (EM) as described in the material and methods (chapter 2).
The TGN-38-HRP fusion protein was efficiently targeted as seen by the presence of 
active HRP to the Golgi complex and in particular it was specific for the TGN network 
and the small vesicles budding off from it, which TGN38 cycles to (Figure 5.7). This 
experiment showed that the TGN-38 chimera could be successfully used as a 
monomer that was specific for the TGN area. Furthermore this specific definition of 
the TGN area showed the ultrastructure in HeLa cells with its stacks and vesicles, 
allowing a definition of its normal structure prior to CLN3 depletion.
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Figure 5.7 TGN-38 HRP chimera expressed in HeLa cells
Electron micrographs of HeLa cells expressing the TGN-38-HRP chimera. Panel A, 
Low magnification of expressing the chimera in the Golgi area, the small arrow heads 
indicate the TGN, where the chimera is expressed as shown by the presence of HRP. 
Large arrow head indicates a subset of Golgi, which is shown, at higher magnification 
in panel B. Panel C and Panel D shows at hight magnification the location of the 
TGN-38-HRP chimera in the TGN, but here the Golgi is shown in a different plane
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with respect to the panel A. The chimera labels just some of the Golgi stacks and 
vesicles close to it (arrows).
Scale bar=100nm
5.4.2 Morphology of the Golgi apparatus Is normal in CLN3 
depleted HeLa cells
To test the hypothesis of a morphological defect at the TGN in CLN3 knock down 
cells, siRNA treated and control cells were processed for electron microscopy.
EM morphological analysis suggested that in both the mock and knock down cells, the 
TGN cisternae were normally organized and connected (Figure 5.8). Also, the vesicles 
in the TGN area were clathrin coated suggesting no evident morphological impairment 
in the CLN3 knock down cells compared to control cells.
Figure 5.8 Golgi morphology in mock and CLN3 siRNA HeLa treated cells
Electron micrograph of the Golgi area in a mock transfected cell (A) and CLN3 
siRNA treated cell (B). CLN3 siRNA does not change the morphology of the Golgi 
area. N=nucleus.
Scale bar=1000 nM
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5 .5  Ultrastructure localization of CIMPR in CD8 fed CLN3 
depleted cells
In CLN3 depleted cells, immunofluorescence studies showed that the CI-MPR was 
confined to the Golgi area in contrast with control cells where it was also present in 
endosomes.
To better define the CI-MPR localization in CLN3 depleted conditions, the analysis of 
its distribution was taken to the ultrastructural level. To directly compare, in parallel, 
the results found so far at the light microscopy level, stable HeLa cells lines 
expressing CD8 -CI-MPR were made and transfected with control siRNA or CLN3 
siRNA. After the second round of transfections. The CD8  antibody was conjugated to 
HRP-Fab fragments (Zenon labelling kit) to be visible using electron microscopy after 
being fed to the cells for 3 hours continuously.
After 3 hours feeding, the control and CLN3 knock down cells were incubated at 4 
degrees for 30 minutes in the presence of diaminobenzidine and hydrogen peroxide to 
reveal the location of the HRP, and subsequently fixed and embedded for electron 
microscopy. The specificity of the HRP-Fab fragments was first proven at the light 
level by indirect immunofluorescence, using an anti HRP antibody to stain the Zenon 
HRP-Fab fragments after the anti CD8  antibody was conjugated to them. The CD8  
antibody conjugated to HRP-Fab fragments was added and left for 3 hours in the 
medium of the cells. Cells were then fixed and labelled with the HRP antibody. The 
HRP antibody recognizes the HRP-Fab fragments and labelled the TGN and a 
population of endosomes in the control cells (Figure 5.9, panel A), but only the Golgi 
area in CLN3 depleted cells (panel B). This differential localization pattern was 
similar to that found when anti CD8  antibody was fed to cells expressing CD8 -CIMPR 
in conjunction with CLN3 knock down and provided evidence that the conjugation of 
the antibody to the Fab fragments did not alter its distribution and its normal 
trafficking.
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Figure 5.9 CD8-CIMPR-HRP in mock and CLN3 siRNA knock down cells
Indirect immunofluorescence of control and CLN3 depleted HeLa cells expressing the 
CD8 -CIMPR chimera, fed for 3 hours with CDS antibody conjugated to HRP-Fab 
fragments and subsequently fixed and labeled with both anti-HRP antibody, used to 
recognize the fragments and a TGN46 antibody. Control cells (A) and CLN3 depleted 
cells (B) differ, as described before in the 5.2.1 paragraph on the CDS localization. In 
the control cells, the CDS antibody is present in both Golgi and endosomes contrasting 
the almost exclusive TGN localization of CDS in CLN3 deficient cells. This 
immunofluorescence demonstrates the specificity of the CDS antibody upon 
conjugation to Fab fragments. Scale bar=10pm
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The combination HRP Zenon-CD8 was then fed for 3 h in mock transfected and CLN3 
siRNA transfected cells which were fixed and prepared for electron microscopy study 
after which the location of the HRP was revealed by the DAB reaction. In the mock 
treated cells, the HRP was detected in the Golgi area, in particular in the TGN 
cisternae (Figure 5.10, panels A and B). It was also present in populations of 
early/recycling endosomes (panel E), in sorting endosomes characterised by having 
few internal vesicles and tubules protruding from the organelles (panel D) and in late 
endosomal structures (panel C).
In CLN3 siRNA cells the HRP was revealed just in the TGN cisternae (Figure 5.11).
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Figure 5.10 HRP Zenon-CD8 feeding in mock transfected HeLa cells
CD8 conjugated to HRP-Fab fragments was fed for 3 hours to mock transfected cells 
was seen in the Golgi area (panel A and B), in recycling/early endosomes (panel E), 
sorting endosomes (panel D), late endosomal structures (panel C) as seen by the 
black/floccular HRP.
N indicates the nucleus 
Scale bar=100 nm
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Figure 5.11 HRP-Zenon-CD8 feeding in CLN3 siRNA HeLa ceils
CDS conjugated to HRP-Fab fragments stains the TGN as seen by the black/floccular 
staining given after the DAB reaction. N indicates the nucleus.
The arrows indicate the presence of clathrin in the TGN area, the same portion of the 
TGN is shown at higher magnification in the small box.
Scale bar=100nm
5.5.1 The route from the endosomes to the lysosomes in CLN3 
depleted cells
As part of its normal trafficking route a fraction of CI-MPR gets endocytosed through 
the PM the location where ligands destined for the lysosomes are bound and 
internalized. Since the bulk of the CI-MPR in CLN3 depleted cells was found mostly 
at the TGN to the detriment of the endosomal population it could be that, in feeding 
experiments, the internalized CI-MPR is mis-trafficked after CLN3 knockdown 
because the plasma membrane-endosomes-lysosomes route is affected.
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To investigate the possibility that the route from the early endosomes to the lysosomes 
is affected by CLN3 knock down, cells were stimulated with fluorescent EGF, which 
traffics from the PM to the early endosomes and then lysosomes for its degradation 
passing by a specific subpopulation of multi vesicular endosomes (White et al., 2006). 
Scrambled and CLN3 siRNA HeLa cells transiently expressing CD8-C1-MPR were 
grown for one hour in the absence of PCS from the media and successively pulsed 
with EGF for 10 minutes and chased for 30 minutes and 2 hours to analyze the 
presence of EGF in early endosomes and lysosomes. After the feeding, cells were 
processed by immunofluorescence and stained with EEAl antibody and LAMPl 
antibody (Figure 5.12). The receptor internalization or progress through the endocytic 
pathway was not disturbed in the knockdown cells. We found that EGF, reached both 
EEAl-positive endosomes and LAMP 1-positive lysosomes at the same rate in the 
knockdown and mock-transfected HeLa cells.
lO’EGF pulse + 30’chase lO’EGF pulse + 2h chase
M O CK CLN3KD MOCK CLN3KD
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Figure 5.12 EGF enters early endosomes and lysosomes in mock and CLN3 
siRNA cells.
White arrow show positive organelles for EGF and EEAl or EGF and Lam pl. Scale 
bar=1 0 pm
5.5.2 Putative role for CLN3 at the TGN exit
In an attempt to further understand which part of the CI-MPR trafficking pathway is 
defective in CLN3 depleted cells a further analysis was done. CLN3 depleted HeLa 
cells and mock transfected controls expressing the CD8 -CI-MPR construct were 
pulsed with the CD8  antibody for 40 minutes in DMEM at 37 degrees to allow the 
internalization o f the reagent in the cells and then chased in full media for 2,5 hours 
(long chase). Cells were subsequently fixed and stained with the TGN46 antibody to 
study the localization of the CD8  antibody. The experiment was designed to reveal 
whether the CI-MPR accumulating within the TGN can be chased out or not.
Figure 5.13 shows that after the long chase the CD8  antibody in the control cells was 
distributed, as expeeted in the TGN and also in the endosomal population. In the 
CLN3 knock down cells, the bulk of the CI-MPR was still present almost exclusively 
at the TGN and a very small function of it was present in endosomes (Figure 5.13). 
This pattern was similar to that seen in cells fed without a chase period (Figure 5.9). 
These data were eonsistent with a failure in exit from the TGN.
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Figure 5.13 Immunofluorescence of mock and CLN3 siRNA treated HeLa cells 
expressing CD8-CI-MPR , fed with CDS for 30 minutes and chased for 2,30h
Indirect immunofluorescence of control and CLN3 depleted HeLa cells expressing the 
CD8 -CI-MPR chimera, fed for 30 minutes with CDS and chased for 2,30 hours. 
Control cells (A) and CLN3 depleted cells (B) differ in CDS localization. In the 
control cells, the CDS antibody is present in both Golgi and endosomes contrasting 
with the almost exclusively localization of CDS in CLN3 deficient cells. This 
immunofluorescence demonstrated that the anterograde route, from TGN to the 
endosomes is affected. Scale bar=10pM.
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5 .6  Discussion
The Mannose 6  phosphate receptors bind newly synthesized lysosomal hydrolases at 
the TGN and deliver them to prelysosomes, then release their cargo to start a new 
cycle (Ghosh et ah, 2003a).
This study showed that cellular depletion of CLN3, using siRNA, interferes with CI- 
MPR localization causing its re-distribution to the TGN and thereby reducing its 
presence in the endosomal population.
Our data support a model where CLN3 is implicated in CI-MPR exit from the TGN. 
We propose that this cellular defect can explain the phenotype of JNCL which is 
characterized by the cellular accumulation of undegraded material.
Hitherto, the reason why cells from JNCL patients accumulate subunit c of the 
mitochondrial ATPase has been a mystery. Now from our experiments we can provide 
evidence that this could be due to a failure of the CI-MPR to deliver lysosomal 
hydrolases.
Analysis of the CI-MPR was carried out after the initial finding that its steady state 
localisation was altered by CLN3 deficiency. This chapter showed a specific block of 
the CI-MPR at the TGN and that after being fed via the plasma membrane, the 
receptor is able to reach the TGN in CLN3 cells but it is not capable of leaving it again 
for a new cycle. Since it does not get degraded, as proved by adding protease 
inhibitors to the cells before CI-MPR feeding, the available explanation is that, 
somehow, CLN3 knock down is interefering with the CI-MPR exit at the TGN. 
CI-MPR leaves the TGN in clathrin coated vesicles and tubules. One possible 
explanation is that these tubules and vesicles cannot form properly or their movement 
is impaired. At the ultrastructural level labelling of CI-MPR with HRP showed that in 
the TGN area HRP-positive clathrin coated vesicles are present and in both mock and 
CLN3 siRNA cells they are positive for CI-MPR. It is possible that perhaps, less CI- 
MPR positive vesicles are present in the CLN3 siRNA cells but this method does not 
allow this to be accurately quantified.
Also, the most consistent noticeable difference between mock and CLN3 siRNA cells 
is the dramatic reduction in CI-MPR from staining in the endosomal population.
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Understanding the mechanism used by CLN3 to generate the phenotype needs further 
work described. CI-MPR leaves the TGN in clathrin coated vesicles with the help of 
AP-1 and GO As. For the future it would be interesting to determine precisely how 
these are functioning in cells deficient for CLN3.
To confirm this work it would be of primary importance to understand which are the 
proteins partners that CLN3 protein interacts with in the cell. Attempts have been 
made to determine CLN3 interactors for example by yeast two hybrid analysis, but this 
has not been possible mainly because of the high hydrophobicity of the protein. It 
could be possible, on the other hand to identify which molecules are upregulated and 
downregulated after CLN3 siRNA treatment.
More easily, the analysis o f the CI-MPR cargo should be done in CLN3 deficient cells 
in order to investigate the effect CLN3 has on the mobility of hydrolases towards the 
lysosomal compartment.
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6 Autophagosom es form from TGN tubular structures 
and CI-MPR redistributes itself in starvation 
conditions
Chapter 3 and chapter 4 showed that there is an increase in the number of 
autophagosomes present in Cln3 KO mouse cells and JNCL I kb CLN3 deletion cells 
and that this aecumulation is likely due to a defect in the clearance of autophagosomes 
arising from compromised fusion of lysosomes with autophagosomes.
It is believed that the fusion between lysosomes and autophagosomes is eritical to the 
degradation o f autophagic content, since of hydrolases likely come from this fusion 
event.
In addition Chapter 5 showed that CI-MPR, an essential receptor for hydrolase 
delivery, is mislocalized to the TGN in CLN3 depleted cells and that CLN3 deficiency 
likely perturbs its exit from the Golgi, thus impairing hydrolases delivery to 
endosomes. This CI-MPR phenotype does not in itself explain a fusion defect between 
lysosomes and autophagosomes but could create such a fusion defect. Also, a more 
general defect in exit from the TGN if this is the case in CLN3 depleted cells could 
lead to a failure to deliver fusion machinery to late endosomes/lyososomes, thus 
explaining or adding the fusion defect also.
In considering how a CI-MPR trafficking defect could impinge on the autophagy 
machinery in cells, it has been reported that, during nutrient deprivation, the CI-MPR 
population moves into vesicular structures (Young et al., 2006), almost completely 
leaving the TGN area. Since this suggests that the receptor could rearrange its cellular 
location when autophagy is stimulated, we have therefore investigated the trafficking 
of CI-MPR in cells starved to stimulate autophagy.
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6,1 CI-MPR is delivered directly to autophagosomes |
HeLa cells expressing CD8 -CIMPR were fed with anti CD8  antibody conjugated to j
ÎHRP-Fab fragments for 2 hours while being grown in BBSS media to induce j
!starvation. After 2 hours, cells were fixed and embedded as usual for EM studies. j
In starved HeLa cells, the HRP, used to reveal the Fab fragments, was present not only |
Iin the TGN but also in new-born autophagosomes, clearly identified by their internal j
!
characteristic cytosolic content (Figure 6.1). In the autophagosomal membrane the ;
j
DAB deposition was strikingly present. The autophagosomes were localized in the j
(
perinuclear area and in close proximity to the Golgi. Different stages of maturation j
{could also be easily identified by their electron density of their contents. i
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Figure 6.1 HRP-Zenon feeding of CD8-CI-MPR stably expressing HeLa cells 
under starvation conditions
HeLa cells expressing CD8 -CI-MPR were grown for 2 hours in EBSS medium to 
induce starvation and fed with anti-CD8  antibody conjugated to HRP Fab fragments, 
then stained with DAB to visualize HRP by electron microscopy.
In A, a forming autophagosome (I), and maturing autophagosomes (II and III); in 
particular III is electron dense suggesting it is in an advanced stage in respect to I and 
II. In B and C other examples of autophagosomes are reported (arrows).
Scale bar=lpm
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The early autophagosomes observed all had HRP positive membranes, which 
suggested that the autophagosomal membrane contains CI-MPR. This together with 
the proximity o f newly formed organelles to the Golgi suggests that the membrane 
may originate from trans Golgi cistemae or tubular endosomes very close to the Golgi. 
In panel A of Figure 6.1, one autophagosome labelled with HRP are not completely 
closed (1) and the autophagic membrane is distinctively tubular (arrows).
In many starved cells, the TGN morphology was altered from normal and become 
become more highly arched in shape (Figure 6.2) as compared with normal Golgi seen 
in Figure 5.7.
Figure 6.2 Golgi morphology of CD8-CIMPR stably expressing HeLa cells fed 
with HRP Zenon-CD8 under starvation conditions.
HeLa cells expressing CD8-C1-MPR were grown for 2 hours in EBSS medium to 
induce starvation and fed with anti-CD8  antibody conjugated to HRP Fab fragments, 
then stained with DAB to visualize HRP by electron microscopy.
Arrows indicate the Golgi complex. HRP visualized with DAB.
Scale bar=l fxm
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Further, only in starved cells, the CI-MPR receptor, in addition to its localisation at the 
TGN and autophagosomal membrane was also present in vesicles which were 
aggregated and tended to be organised in patches (Figure 6.3 panel A and B, arrow 
head). Sometimes they appeared to be in between the TGN apparatus and the rest of 
the Golgi (arrows) and sometimes further away and separated from the Golgi. The 
vesicles were also seen outside the newly forming autophagosome, and some were 
also seen inside the same autophagosomes (Figure 6.4). At first sight it seemed that the 
vesicles could have been entrapped with the cytosol at the moment of 
autophagosomal formation. However, the process seems more complicated since some 
vesicles were in the process of fusion or “budding in”, to the newly formed organelle 
as suggested by the connection with the autophagosomal membrane (arrows). These 
vesicles could be delivering cargo, such as that carried by the CI-MPR, to the 
autophagosomes (Figure 6.4).
Figure 6.3 Vesicle aggregates in CD8-CIMPR stably expressing HeLa cells fed 
with HRP Zenon-CD8 under starvation conditions
HeLa cells expressing CD8 -CI-MPR were grown for 2 hours in EBSS medium to 
induce starvation and fed with anti-CD8  antibody conjugated to HRP Fab fragments, 
then stained with DAB to visualize HRP by electron microscopy.
Arrows indicate clusters of vesicles. HRP visualized with DAB.
Scale bar=l[xm
152
Chapter 6 Autophagosomes origin and CI-MPR distribution during starvation
Figure 6.4 Vesicles in proximity to and inside newly formed autophagosomes in 
CD8-CIMPR stably expressing HeLa cells fed with HRP Zenon-CD8 under 
starvation conditions
HeLa cells expressing CD8 -CI-MPR were grown for 2 hours in EBSS medium to 
induce starvation and fed with anti-CD8  antibody conjugated to HRP Fab fragments, 
then stained with DAB to visualize HRP by electron microscopy.
Arrow indicate vesicle presumably in the process of ‘budding in” newly formed 
autophagosomes. HRP visualized with DAB.
Scale bar=lpm
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6.1.1 Starvation Induced autophagy In human skin fibroblasts, 
shows that the formation of vesicle clusters is not cell 
dependent
The observations above suggested that autophagosomes could arise from the TGN or 
endosomes where the CI-MPR cycles to. In addition, the presence of vesicular 
aggregates suggest a vesicular route from the TGN to the newly forming 
autophagosomes rather then the TGN directly vyrapping itself into an autophagosomal 
sourronding membrane. To examine if the formation of vesicle aggregates was a 
characteristic and a specific feature of HeLa cells under starvation conditions, another 
cell type was analysed. Human skin fibroblasts (BR3 cell line) were also subjected to 
2 hours of nutrient deprivation and prepared for electron microscopy. At the EM level, 
double membrane bound autophagosomes were detected in proximity to the Golgi 
(Figure 6.5) and many vesicles were detected inside the newly formed 
autophagosomes and also in their proximity (panel A, C and D). In some cells it was 
also possible to see in maturing autophagosomes not only cytosol with vesicles, but 
also organelles such as mitochondria and ER (panel B).
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Figure 6.5 Autophagosome formation in human skin fibroblasts under starvation 
conditions
Human skin fibroblasts grown for not more than 20 passages, were treated for 2 hours 
with EBSS media to induce starvation. Starvation induces the formation of 
autophagosomes in the proximity of the Golgi. Many vesicles cluster around them and 
are present in the same newly formed organelles.
Arrows indicate autophagosomes, m=mitochondria 
Scale bar=0.5u.m
155
Chapter 6 Autophagosomes origin and CI-MPR distribution during starvation
The forming autophagosomes were often seen in very close proximity to the ER 
(Figure 6.6).
i
Figure 6.6 Autophagosome in close proximity to the ER
Human skin fibroblasts grown for not more than 20 passages, were treated for 2 hours 
with EBSS media to induce starvation. Starvation induces the formation of 
autophagosome (arrow). Often autophagosomes are in proximity of the ER.
Scale bar=0.5pm
6.2 Discussion
Stable CD8-CI-MPR-expressing HeLa cells were used to visualize the localization of 
CI-MPR after feeding of anti-CD8 conjugated to Zenon-HRP-Fab fragments to cells in 
starvation conditions. It was found that CI-MPR changes its localization after 
induction of autophagy. As shown in chapter 5 by electron microscopy, CD8-CI-MPR 
is present in the TGN, in a few clathrin coated vesicles in the TGN area, and in 
endosomes. After starvation, we observed that CI-MPR was now present in many 
small vesicles organized in patches and along the newly forming autophagosomes that 
were not present under normal growth conditions.
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In particular, the newly formed autophagosmal membranes were positive for CI-MPR, 
indicating that the formation of the autophagosomal membrane may arise by fusion of 
vesicles budded from the TGN or associated endosomes. This morphology 
emphasized how the TGN is in close association with newly forming autophagosomes, 
which are distinguished by their cytosolic content. One of the main unanswered 
questions about autophagy is the source of the autophagosomal membrane. Golgi and 
ER have been suggested already as possible autophagosomal membrane sources 
(Mijaljica et al., 2006) but there is no firm proof to confirm this hypothesis. These 
results provide evidence to suggest that that the major source of autophagosome 
membranes in HeLa cells could be the TGN. In fibroblasts where autophagy was 
induced by starvation in the same way as for HeLa cells, we found that the 
ultrastructure of the forming autophagosomes was different. In particular, in 
fibroblasts a characteristic phagophore and early autophagosome with double 
membrane was observed, in contrast to HeLa cells, where early autophagosomes were 
single-membrane bound and the traditionally reported phagophore with layers of 
membranes was not found. Also, in HeLa cells the TGN occasionally showed 
membrane protrusions and it is possible to speculate that the membranes that arise 
from these could be autophagosomal membranes.
The most striking finding was probably the unexpected clustering of CI-MPR positive 
vesicles.
In starved cells autophagosomes undergo ultrastruetural changes as they form and 
mature. This can include an increase in density and contents and changes in size. After 
induction of starvation with EBSS media, newly formed structures can be observed 
and their content is initially cytosolic.
The presence of CI-MPR in autophagosomes has already been addressed in the 
literature, and it has been established that the receptor is present in low levels, along 
with acid phosphatase and cathepsins in maturing autophagosomes (Tooze et a l, 
1990).
In mature autophagosomes, the level of cathepsins, especially cathepsin D, and CI- 
MPR are much higher (Tooze et a l, 1990). Here, by using a very sensitive EM 
approach we have uncovered new details on CI-MPR recruitment to the
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autophagosomes as they mature have been defined and form the basis for further 
investigation.
It has been reported that the CI-MPR does not appear to be increased after the 
induction of autophagy (Tooze et ah, 1990). However it was found that the receptors 
localization shifts, into vesicles organized in patches.
Moreover, the proximity of the CI-MPR vesicles to the newly formed autophagosomes 
was striking. In addition, the CI-MPR positive vesicles were found inside the 
autophagosomes, not just randomly distributed inside the autophagic organelles but 
specifically adjacent to their internal edges. It is not clear why these vesicles are 
present inside the autophagosomes but it could be speculated that they may contain not 
only CI-MPR but other molecules needed for the maturation of the autophagosomes.
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7 Summary, discussion and future work
In this thesis we attempted to discover the function of CLN3 by determing the 
phenotypes arising from its loss as seen at the light and ultrastruetural level of 
morphology. From this descriptive work we hoped to infer CLN3 function.
Discovery of the function of CLN3 is fundamental to understand the basis of Juvenile 
Batten disease. Two major findings were observed and described, one regarding the 
abnormal accumulation of autophagosomes (chapter 3 and 4) in CLN3 cells and the 
other concerning the block of CI-MPR in the TGN (chapter 5). Furthermore, a small 
study was made of the origin of autophagosome membranes in relation to CI-MPR 
(chapter 6) and TGN.
7.1 Lysosome and autophagosome meeting point
Similarly to what has been shown for Batten disease, other neurodegenerative diseases 
present with an abnormal accumulation of autophagic vacuoles, establishing that the 
autophagic pathway exerts a primary role in neurodegeneration. (Nixon et al., 2005) 
(Rubinsztein et al., 2005) (Nixon, 2006)
In addition, it has been postulated that the autophagosome accumulation seen in some 
lysosomal storage diseases is due to defective clearance by autophagosome-lysosome 
fusion (Settembre et al., 2007) even if the mechanism still remains to be clarified 
(Settembre et al., 2008). Few hypotheses have been made, but one possible mechanism 
is an impairment of vesicular trafficking due to defects in microtubules, which has 
been shown to cause a block in autophagosome-lysosome fusion when disrupted 
(Kochi et al., 2006; Webb et al., 2004). A link between CLN3 and microtubules has 
been made, since CLN3 overexpression causes the microtubular binding protein 
HOOKl to dissociate from microtubules and to aggregate(Luiro et al., 2004).
In phagocytosis, a different, but clearly related pathway, fusion between lysosomes 
and phagosomes is arrested due to a defective lysosomal distribution in cells deficient 
for Lampl/Lamp2. The lysosomes in these cells are more dispersed than in the wild
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type due to altered dynein-mediated transport of lysosomes which is depressed in 
Lamp-KO cells (Huynh et a l, 2007).
Another possible mechanism underlying autophagic compartment expansion in 
lysosomal storage disorders involves changes in the lipid composition in the lysosome 
membranes leading to impairment of fusogenic and transport mechanism. This could 
occur in cholesterol and glycosphingolipids accumulating lysosomal storage disorders 
such as Niemann Pick disease (Ko et a l, 2005) (Soho et a l, 2007). Thirdly and more 
applicable to JNCL, a defect in endosomal trafficking could also be responsible for 
perturbing autophagosomal maturation (Settembre et a l, 2008).
It is possible the basis of this phenomena could be due to a combination of these 
effects.
To determine which step in autophagosome maturation is affected in cells after loss of 
CLN3 in JNCL, both light and electron microscopy approaches were employed. A 
good approach to investigate if the relationship between lysosomes and 
autophagosomes was found using HRP feeding and electron microscopy. This showed 
that none of the autophagosomes accumulating in CLN3 MEFs KO were reached by 
an endocytic tracer. Previously, it was reported using pancreatic cells that 
autophagosomes fuse with components of the endocytic pathway just 20 minutes after 
induction of autophagy (Tooze et al., 1990). Here we allowed more than one hour for 
the tracer to reach the entire endocytic machinery (Tooze et a l, 1990) but it was able 
just to fill the endocytic pathway, not the JNCL autophagosomes.
Also subunit c, the mitochondrial marker which accumulates in JNCL patient cells, 
was found just in the autophagosomes and not in the lysosomes by cryo electron 
microscopy.
We therefore propose that the autophagic pathway in CLN3 deficient cells is arrested 
and either no fusion or very delayed fusion occurs with the components of the 
endocytic pathway. Sparse Lampl gold particles were found in cryo sections labelling 
the autophagosomes. It is believed that Lampl is recruited to autophagosomes as a 
consequence of fusion with lysosomes but no fusion was observed between 
endosomes and autophagosomes in CLN3 deficient cells so it would be possible that 
Lampl could get partially recruited directly to autophagosomes via TGN. We here
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proved that the maturation of the autophagosomes is arrested in CLN3 deficient cells 
and no fusion events of autophagosomes with lysosomes occurs or it is very delayed. 
Since it is currently only possible to examine the relationship between 
autophagosomes and endosomes using electron microscopy due to the paucity of 
autophagosomal markers we decided to investigate if phagocytosis, another pathway 
which involves fusion events and a tight relationship to the endocytic pathway, is 
impaired in JNCL due to impaired fusion with endosomes. Phagosomes need to fuse 
with endosomes to mature (Tjelle et al., 2000; Vieira et al., 2002) in a similar way to 
autophagosomes (Bampton et ah, 2005). In CLN3 deficient cells a striking delay in 
fusion events occurred between phagosomes both late and early endosomes was 
observed.
Light and electron microscopy evidence suggested that the interaction between 
phagosomes with lysosomes was impaired, as was observed for the autophagic 
pathway. Although autophagic and phagocytic pathways cannot be direcly compared 
due to the differences in origin of phagosomes and autophagosomes, both do have in 
common the necessity for these multiple interactions with the endocytic pathway.
To continue the work on autophagy it would be very helpful to have to hand new 
markers which specifically recognize the organelles from their intitial formation. 
Otherwise accurate analysis relies on electron microscopy study. In particular it is 
critical to understand at which point CLN3 is recruited to the autophagosomal 
membrane. In addition, there are other components that should be investigate, for 
example Lamp2 (Eskelinen et ah, 2002) which has been shown to exert a role in 
fusion between phagosomes and lysosomes.
7.1.1 SNARE mediated membrane fusion
To better study fusion defects, it would also be critical to identify new SNAREs which 
must be present in the membranes of the autophagosomes. There are over 30 SNARE 
family members in mammalian cells and each one is found in a distinct subcellular 
compartment (Chen and Scheller, 2001).
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In this work the presence of Syntaxin 8 was identified in LC3 positive organelles. 
Syntaxin 8 forms a complex with Vtlb, endobrevinA^amp8 and Syntaxin 7; and it is 
localized mostly in late endosomes/lysososomes (Pryor et ah, 2004). In LC3-EGFP 
stable expressing cells we observed the presence of Syntaxin 8 in autophagosomes, 
and sometimes Syntaxin 8 was found colocalizing with LC3 before Lampl was 
recruited.
No difference in Syntaxin 8 distribution was observed after CLN3 knock down. 
Syntaxin 8 stability is due to another SNARE, Vtlb. In V tlb KO mice, Syntaxin 8 
levels are reduced due to degradation of the protein and cells from the liver presented 
an abnormal accumulation of autophagosome and MVBs (Atlashkin et al., 2003). Vtlb 
may control the stability of Syntaxin 8 and the interaction of the two SNAREs could 
somehow exert a role in the fusion of autophagosomes with MVBs or lysosomes. For 
this reason it would be of great interest to analyse in detail both Syntaxin 8 and Vtlb 
in relation to autophagy to better understand and its mechanism and the 
interconnections with endosomes.
7 .1 .2  P h a g o c y t o s i s  d e f e c t s  in CLN3 d e f ic ie n t  c e l l s
Phagocytosis was found to be defective in CLN3 KO mouse embryonic fibroblasts 
transfected with FcR and allowed to internalize latex beads opsonized with human IgG 
(Chapter 4). We showed that CLN3 deficient cells are able to internalize latex beads 
but a delay of fusion events occurs as was demonstrated by delay of recruitment of 
endocytic markers to maturing phagosomes.
To further this phagocytosis study in the future, it would be worth looking at 
professional phagocytic cells isolated from ClnS mice, rather than engineered 
phagocytic fibroblasts.
A major defect in phagocytosis has not been reported in patients with Batten disease, 
although bacterial respiratory infections have been noted in Finnish patients (Dr. Laura 
Aberg, University of Helsinki, personal communication). The leading symptom in 
JNCL/Batten disease is blindness associated with retinitis pigmentosa and 
photoreceptor cell death. The retinal pigment epithelia cells are a major site of
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phagocytosis, digesting shed photoreceptor outer segments. RPE cells have not been 
reported to be deficient in Batten disease, but phagocytosis in the Cln3 mice is 
currently being examined by EM in collaboration with Dr Clare Putter (UCL). 
Previously examined samples from ClnS KO brains showed an accumulation of large 
amounts of storage material in microglial cells, suggesting that these professional 
phagocytes are able to phagocytose properly but are not able to digest (Mitchison and 
Turmaine, unpublished). Similar microglial storage accumulation is seen in JNCL 
brains by many. Both ClnS KG mouse and ClnS^^^^^  ^ show prominent and enlarged 
microglia in brain (Pontikis et al., 2004) (Pontikis et al., 2005) similar to JNCL brains 
(Tyynela et ah, 2004).
As demonstrated in chapter 4, using engineered phagocytic cells, the defect is 
probably a deficiency in fusion of phagosomes with the endocytic compartment.
In conclusion, it is necessary to continue investigating the phagocytic pathway, since 
this could be responsible in part, for cell death in JNCL patients.
7.2 Batten disease and CI-MPR
After CLN3 depletion, CI-MPR is almost exclusively localized at the TGN.
Anti-CD8 antibody feeding in CLN3 siRNA HeLa cells that were also transfected with 
CD8-CIMPR showed re-localization of CI-MPR to the Golgi area resulting from 
CLN3 depletion. In particular, a 30 minute pulse of CD8 antibody in these cells with a 
more than 2 hours ehase, resulted in an even tight localization of CI-MPR at the TGN. 
Together this indicates that CI-MPR is specifically blocked in the TGN after CLN3 
knock down.
One of the CI-MPR functions is to deliver hydrolases to the lysosomes. If the 
trafficking of this essential receptor is impaired it could result in reduced hydrolase 
delivery to the lysosomes with a knock on effect of increased secretion of hydrolases. 
Time did not allow an analysis of cargo delivery in CLN3 depleted cells, but an 
important assay would be investigating targeting and secretion of cathepsin D and 
other lysosomal hydrolases.
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CI-MPR binds the hydrolases at the TGN and is directed to endosomes in clathrin 
coated vesicles (CCV) that bud from the TGN.
It was reported that CLN3 localization to lysosomes is dependent on direct interaction 
with AP-1 and AP-3 (Kyttala et aL, 2005) although this remains controversial (Storch 
et al., 2004). If AP-1 directly interacts with CLN3, it could be that this interaction is 
crucial to the exit o f CI-MPR from the clathrin-coated vesicles. It will be critical in 
future to understand how the proteins involved in CI-MPR exit from the TGN and 
CLN3 interact.
After CLN3 siRNA, we found that CI-MPR re-distributes localizing almost 
exclusively at the TGN. Electron microscopy analysis showed that CI-MPR is present 
not only along the TGN ribbon but also in clathrin coated vesicles in the TGN area. A 
quantification of these clathrin coated vesicles and also vesicles that are not clathrin 
coated is crucial to continue this work on understanding if CI-MPR is less present in 
these vesicles. In the scenario that there is less CI-MPR present in clathrin coated 
vesicles it would be worth checking the level of GGAs, since they have been shown to 
be likely to be important for bringing CI-MPR to CCVs and so are closely involved in 
budding events.
In future work it would also be of vital importance to repeat and confirm by EM 
experiments on CI-MPR localization using an antibody that can recognize the 
endogenous protein. Electron microscopy experiments provided evidence that CI- 
MPR is localized at the TGN but investigation of the endogenous protein would be 
more meaningful and might supply more information about the exact distribution. It is 
possible that the overexpression of the CD8-CI-MPR construct used here could cause 
the CI-MPR to “fill” in all of the TGN ribbon, and thereby prevent discovery of a 
subdomain.
TGN exit is the main defect observed after CLN3 siRNA. From the TGN, membrane 
carriers and clathrin coated vesicles form and bud off in order to be transported to the 
PM or endosomes respectively. At the TGN a segregation process occurs and different 
cargos are sorted into different carriers. For example the VSGV protein is sorted at the 
Golgi into carriers and not in clathrin coated vesicles for destination at the PM; these 
constitutive secretory carriers do not colocaJize with CI-MPR or Furin (Polishchuk et
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al., 2003). The VSVG protein could be used as a control in future work, to prove the 
specificity or not of the role of CLN3 in blocking CI-MPR exit. In conclusion, it 
remains to be determined if the block at the TGN caused by CLN3 is specific for CI- 
MPR; other receptors may also be impaired, such as sorLA or sortillin.
Knock down of GGAs or AP-1 causes a bypass of TGN-lysosome targeting and 
causes hydrolases to be secreted. It would be desirable to test whether after CLN3 
knock down there is secretion of lysosome hydrolases. In particular cathepsin D which 
is employed in subunit c degradation.
It has been shown that CLN3 deficiency causes defects in cathepsin D processing but 
it still remains to be established whether this enzyme is actually secreted from CLN3 
deficient cells (Golabek et al., 2000) (Fossale et al., 2004).
In conclusion, two important question marks remain for the role of CLN3 in the CI- 
MPR block at the TGN: establishing the relationship between the two proteins and 
also their interaction scheme with the GGA and AP-1 proteins.
It was recently reported that depletion of Vps24 (ESCRTIII) increases the amount of 
CI-MPR and the receptor localizes in the Golgi. Further, the Golgi is fragmented 
suggesting that Vps24 controls recycling to the Golgi of one or more factors that 
mantain its integrity (Raiborg et al., 2007). Since in our hands, loss of CLN3 does not 
fragment the Golgi but tightens up the ribbon, we would argue that a different 
mechanism is being used.
7.3 Autophagy: a new due to the origin of autophagosomal 
membrane
One of the major phenotypic characteristics in CLN3 deficient cells is the 
accumulation of autophagosomes.
CI-MPR recruitment to autophagosomes has been analysed in pancreatic cells and it 
was observed that a low level of CI-MPR was present in maturing autophagosomes 
but a higher level was found in autophagosomes fused with lysosomes (Tooze et al., 
1990).
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In chapter 6 we tried to link the CI-MPR block caused by CLN3 deficiency and the 
formation of autophagosomes by inducing starvation in CD8-CI-MPR expressing cells 
and simultaneously feeding CD8 conjugated to HRP-Fab fragments.
In this study we could confirm the presence of CI-MPR in maturing autophagosomes 
in HeLa cells. Additionally we noticed that CI-MPR is recruited very early after the 
formation of autophagosomes, likely even before a fusion with endosomes had 
occurred, as judged on morphological criteria.
We also found that after starvation, CI-MPR distributes itself in vesicles that are 
located in near proximity to the TGN, most often organized in clusters. The EM 
clearly implied that the CI-MPR positive vesicles are destined for delivery to the 
autophagosomes. It seems possible that vesicles-based delivery of CI-MPR is 
necessary for the initial formation of the autophagosomes.
It is also possible to speculate that, in Batten disease the autophagosomal maturation 
defect is due not only to missing interactions between autophagosomes and endosomes 
but also due a defect in formation revealed by the missing delivery of CI-MPR.
It would be challenging to understand the function of the CI-MPR containing vesicles. 
One hypothesis is that these vesicles could bring proton pumps to the 
autophagosomes, for their initial acidification: it was reported that acidification occurs 
while the autophagosomes mature by staining with DAMP (Tooze et al., 1990) and 
that autophagosomal acidification could in fact occur before the fusion of 
autophagosomes with the lysosomes.
Futher experiments are required to confirm which molecules the CI-MPR-positive 
vesicles are bringing to the autophosomes and it is intriguing to consider that 
autophagosomes might be maturing independently of the endocytic pathway.
It would be of interest to investigate the only transmembrane protein conserved across 
species, member o f the Atg family called Atg9 (Noda et al., 2000). This 
transmembrane protein localizes at the PAS and in the cytosol in yeast, and traffics 
between PAS and non-PAS structures (usually mitochondria) thus potentially being 
involved in autophagosome formation (Reggiori et al., 2005). In mammalian cells 
Atg9 traffics from the TGN, from where it is usually presented to endosomes in 
starvation conditions, but it is not found in mitochondria (Young et al., 2006). ULKl
166
Chapter 7 Summary, discussion and future work
(Atgl) siRNA inhibits the starvation-induced redistribution of Atg9 and it stays in the 
TGN. It was reported in the same work that after starvation CI-MPR traffics in the 
same way as Atg9, when the CI-MPR TGN population moves to the endosomes in 
starvation conditions (Young et ak, 2006). It would be extremely interesting to 
observe Atg9 behaviour in CLN3 depleted cells.
Due to paucity of markers there is currently no way to distinguish (except by 
morphology), the initial stage of autophagosome formation since even LC3 gets 
recruited late and is therefore not a good early marker. Additionally, in conventional 
cryo-fixation samples the preservation is not good enough to distinguish the first 
stages of autophagosomal maturation. In addition, new techniques need to be 
developed. In chapter 6 we suggested that the TGN changes morphology after 
induction of autophagy and sometimes protrusions are observed. It would therefore be 
of great interest to apply the high pressure freezing technique to improve the 
resolution of the TGN (Zenner et al., 2007). Another development that should also be 
considered is a new approach combining high pressure freezing with the use of less 
conventional resin that allows gold particle staining for immunolocalisation purposes 
(Hawes et al., 2007).
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